Loading...

Paolo Casali

Title(s)Professor Emeritus, Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-4456
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
    NIH T32AI138944Aug 13, 2018 - Jul 31, 2023
    Role: Co-Principal Investigator
    Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1
    NIH R01AI105813Feb 1, 2014 - Jan 31, 2024
    Role: Principal Investigator
    Epigenetic downregulation of the antibody response and inhibition of autoimmunity
    NIH R56AI105813Jun 14, 2013 - Jan 31, 2014
    Role: Principal Investigator
    Immunoglobulin class switch DNA recombination
    NIH R56AI045011Aug 1, 2012 - Jul 31, 2014
    Role: Principal Investigator
    Rab7 and estrogen-ER as B cell-intrinsic mediators of auto/antibody responses
    NIH R01AI079705Jul 1, 2008 - Nov 30, 2020
    Role: Principal Investigator
    Molecular mechanisms in the generation of autoantibodies and lupus
    NIH R56AI079705Jul 1, 2008 - Dec 14, 2009
    Role: Principal Investigator
    Immunology Research Training Grant
    NIH T32AI060573Jul 1, 2004 - Aug 31, 2015
    Role: Co-Principal Investigator
    Immunoglobulin class switch DNA recombination
    NIH R01AI045011May 1, 2000 - Dec 14, 2006
    Role: Principal Investigator
    Immunology and Microbial Pathogenesis Research Training Program
    NIH T32AI007621Sep 1, 1999 - Aug 31, 2016
    Role: Co-Principal Investigator
    AGING--ANTIBODY RESPONSE TO BACTERIAL AND VIRAL AGS
    NIH R01AG013910Aug 15, 1997 - Jul 31, 2003
    Role: Principal Investigator
    MOLECULAR IMMUNOBIOLOGY OF AIDS-LYMPHOMA
    NIH R01CA068541Jan 19, 1995 - Dec 31, 1998
    Role: Principal Investigator
    HUMAN ANTIBODY V GENES--GENOMIC ORGANIZATION/EXPRESSION
    NIH R13AI036255Jul 1, 1994 - Jun 30, 1995
    Role: Principal Investigator
    SOMATIC HYPERMUTATION IN HUMAN B CELLS
    NIH R01AR040908Feb 1, 1992 - Dec 31, 1995
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med. 2021 Mar 13. Frezza AM, Ravi V, Lo Vullo S, Vincenzi B, Tolomeo F, Chen TW, Teterycz P, Baldi GG, Italiano A, Penel N, Brunello A, Duffaud F, Hindi N, Iwata S, Smrke A, Fedenko A, Gelderblom H, Van Der Graaf W, Vozy A, Connolly E, Grassi M, Benjamin RS, Broto JM, Grignani G, Jones RL, Kawai A, Tysarowski A, Mariani L, Casali PG, Stacchiotti S. PMID: 33713582.
      View in: PubMed   Mentions:    Fields:    
    2. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network. ESMO Open. 2021 Mar 10; 6(2):100083. Frezza AM, Napolitano A, Miceli R, Badalamenti G, Brunello A, Buonomenna C, Casali PG, Caraceni A, Grignani G, Gronchi A, Infante G, Morosi C, Saita L, Simeone N, Zaffaroni N, Vincenzi B, Stacchiotti S. PMID: 33714008.
      View in: PubMed   Mentions:
    3. Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation. J Exp Clin Cancer Res. 2021 Mar 01; 40(1):83. Zuco V, Pasquali S, Tortoreto M, Brich S, Percio S, Dagrada GP, Colombo C, Sanfilippo R, Lauricella C, Gounder M, El Bezawy R, Barisella M, Dei Tos AP, Casali PG, Gronchi A, Stacchiotti S, Zaffaroni N. PMID: 33648535.
      View in: PubMed   Mentions:    Fields:    
    4. Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect? Ann Surg Oncol. 2021 Jan 28. Danieli M, Barretta F, Fiore M, Radaelli S, Sangalli C, Barisella M, Stacchiotti S, Palassini E, Miceli R, Callegaro D, Casali PG, Gronchi A. PMID: 33511543.
      View in: PubMed   Mentions:    Fields:    
    5. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), Spanish Group for Research on Sarcomas (GEIS). Ann Oncol. 2021 Jan 19. Casali PG, Le Cesne A, Velasco AP, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Penel N, Hartmann JT, Duffaud F, Goldstein D, Broto JM, Gronchi A, Wardelmann E, Marréaud S, Zalcberg JR, Litière S, Blay JY. PMID: 33482247.
      View in: PubMed   Mentions:    Fields:    
    6. Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]. Eur J Cancer. 2021 Feb; 144:397-398. Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. PMID: 33353792.
      View in: PubMed   Mentions:    Fields:    
    7. Evaluating the effectiveness of clinical ethics committees: a systematic review. Med Health Care Philos. 2020 Nov 21. Crico C, Sanchini V, Casali PG, Pravettoni G. PMID: 33219898.
      View in: PubMed   Mentions:    Fields:    
    8. Epigenetics of the antibody and autoantibody response. Curr Opin Immunol. 2020 Dec; 67:75-86. Moroney JB, Chupp DP, Xu Z, Zan H, Casali P. PMID: 33176228.
      View in: PubMed   Mentions:
    9. Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells. Nat Commun. 2020 10 28; 11(1):5435. Moroney JB, Vasudev A, Pertsemlidis A, Zan H, Casali P. PMID: 33116135.
      View in: PubMed   Mentions:
    10. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network. Cancer. 2021 Feb 15; 127(4):569-576. Stacchiotti S, Simeone N, Lo Vullo S, Baldi GG, Brunello A, Vincenzi B, Palassini E, Dagrada G, Collini P, Morosi C, Greco FG, Sbaraglia M, Dei Tos AP, Mariani L, Frezza AM, Casali PG. PMID: 33107985.
      View in: PubMed   Mentions:
    11. Data protection and research in the European Union: a major step forward, with a step back. Ann Oncol. 2021 01; 32(1):15-19. Casali PG, Vyas M. PMID: 33096210.
      View in: PubMed   Mentions:
    12. In Reply. Oncologist. 2020 12; 25(12):e2018. Stacchiotti S, Baldi GG, Casali PG. PMID: 32918787.
      View in: PubMed   Mentions:
    13. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer. 2020 11; 139:149-168. Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. PMID: 32992154.
      View in: PubMed   Mentions:
    14. When does a new sarcoma exist? Clin Sarcoma Res. 2020; 10:19. Casali PG, Dei Tos AP, Gronchi A. PMID: 32944215.
      View in: PubMed   Mentions:
    15. Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers. Clin Sarcoma Res. 2020; 10:17. Fucà G, Fabbroni C, Mancari R, Manglaviti S, Bogani G, Fumagalli E, Bertulli R, Morosi C, Collini P, Raspagliesi F, Colombo N, Casali PG, Sanfilippo R. PMID: 32874547.
      View in: PubMed   Mentions:
    16. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis. Oncologist. 2020 11; 25(11):e1777-e1784. Baldi GG, Brahmi M, Lo Vullo S, Cojocaru E, Mir O, Casanova M, Vincenzi B, De Pas TM, Grignani G, Pantaleo MA, Blay JY, Jones RL, Le Cesne A, Frezza AM, Gronchi A, Collini P, Dei Tos AP, Morosi C, Mariani L, Casali PG, Stacchiotti S. PMID: 32584482.
      View in: PubMed   Mentions:
    17. Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review. ESMO Open. 2020 07; 5(4). Raimondi A, Simeone N, Guzzo M, Maniezzo M, Collini P, Morosi C, Greco FG, Frezza AM, Casali PG, Stacchiotti S. PMID: 32661185.
      View in: PubMed   Mentions:
    18. Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors. Clin Cancer Res. 2020 Oct 15; 26(20):5534-5538. Sanfilippo R, Fabbroni C, Fucà G, Fumagalli E, Morosi C, Sbaraglia M, Gronchi A, Collini P, Dei Tos AP, Casali PG. PMID: 32605908.
      View in: PubMed   Mentions:
    19. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). Int J Gynecol Cancer. 2020 Oct; 30(10):1633-1637. Ray-Coquard I, Hatcher H, Bompas E, Casado A, Westermann A, Isambert N, Casali PG, Pratap S, Stark D, Valverde C, Anand A, Huizing M, Floquet A, Lindner L, Hermes B, Seddon B, Coens C, Jones R, Reed N. PMID: 32546554.
      View in: PubMed   Mentions:
    20. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. JAMA Surg. 2020 06 01; 155(6):e200397. Gronchi A, Bonvalot S, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom HJ, van Coevorden F, Penel N, Kopp HG, Duffaud F, Goldstein D, Broto JM, Wardelmann E, Marréaud S, Smithers M, Le Cesne A, Zaffaroni F, Litière S, Blay JY, Casali PG. PMID: 32236507.
      View in: PubMed   Mentions:
    21. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J Clin Oncol. 2020 07 01; 38(19):2178-2186. Gronchi A, Palmerini E, Quagliuolo V, Martin Broto J, Lopez Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz Beveridge R, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Braglia L, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. PMID: 32421444.
      View in: PubMed   Mentions:
    22. The sacral chordoma margin. Eur J Surg Oncol. 2020 08; 46(8):1415-1422. Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio JM, Bandiera S, Boglione A, Boland P, Bolle S, Bruland Ø, Brunello A, Bruzzi P, Campanacci D, Cananzi F, Capanna R, Casadei R, Cordoba A, Court C, Dei Tos AP, DeLaney TF, De Paoli A, De Pas TM, Desai A, Di Brina L, Donati DM, Fabbri N, Fiore MR, Frezza A, Gambarotti M, Gasbarrini A, Georg P, Grignani G, Hindi N, Hug EB, Jones R, Kawai A, Krol AD, Le Grange F, Luzzati A, Marquina G, Martin-Benlloch JA, Mazzocco K, Navarria F, Navarria P, Parchi PD, Patel S, Pennacchioli E, Petrongari MG, Picci P, Pollock R, Porcu L, Quagliuolo V, Sangalli C, Scheipl S, Scotto GM, Spalek M, Steinmeier T, Timmermann B, Trama A, Uhl M, Valverde C, Varga PP, Verges R, Weber DC, Zoccali C, Casali PG, Sommer J, Gronchi A. PMID: 32402509.
      View in: PubMed   Mentions:
    23. Correction: B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching. J Immunol. 2020 Jun 01; 204(11):3058. Yan H, Fernandez M, Wang J, Wu S, Wang R, Lou Z, Moroney JB, Rivera CE, Taylor JR, Gan H, Zan H, Kovalskyy D, Liu D, Casali P, Xu Z. PMID: 32277056.
      View in: PubMed   Mentions:
    24. The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group. Eur J Surg Oncol. 2020 07; 46(7):1320-1326. Frezza AM, Sbaraglia M, Lo Vullo S, Baldi GG, Simeone N, Frenos F, Campanacci D, Stacchiotti S, Pasquali S, Callegaro D, Gambarotti M, Barisella M, Palomba A, Mariani L, Casali PG, Dei Tos AP, Gronchi A. PMID: 32307188.
      View in: PubMed   Mentions:
    25. B cell Sirt1 deacetylates histone and non-histone proteins for epigenetic modulation of AID expression and the antibody response. Sci Adv. 2020 04; 6(14):eaay2793. Gan H, Shen T, Chupp DP, Taylor JR, Sanchez HN, Li X, Xu Z, Zan H, Casali P. PMID: 32270032.
      View in: PubMed   Mentions:
    26. Estrogen Reverses HDAC Inhibitor-Mediated Repression of Aicda and Class-Switching in Antibody and Autoantibody Responses by Downregulation of miR-26a. Front Immunol. 2020; 11:491. Casali P, Shen T, Xu Y, Qiu Z, Chupp DP, Im J, Xu Z, Zan H. PMID: 32265934.
      View in: PubMed   Mentions:
    27. Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin. Br J Cancer. 2020 Mar; 122(7):1120. Bello E, Brich S, Craparotta I, Mannarino L, Ballabio S, Gatta R, Marchini S, Carrassa L, Matteo C, Sanfilippo R, Gronchi A, Casali PG, Pilotti S, D'Incalci M, Frapolli R. PMID: 32047297.
      View in: PubMed   Mentions:
    28. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). ESMO Open. 2020 03; 5(2). Casali PG, Trama A. PMID: 32220947.
      View in: PubMed   Mentions:
    29. Correction: Combination of PPAR? Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. Clin Cancer Res. 2020 Mar 01; 26(5):1199. Frapolli R, Bello E, Ponzo M, Craparotta I, Mannarino L, Ballabio S, Marchini S, Carrassa L, Ubezio P, Porcu L, Brich S, Sanfilippo R, Casali PG, Gronchi A, Pilotti S, D'Incalci M. PMID: 32122930.
      View in: PubMed   Mentions:
    30. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry. ESMO Open. 2020 03; 5(2). Stahel RA, Lacombe D, Cardoso F, Casali PG, Negrouk A, Marais R, Hiltbrunner A, Vyas M. PMID: 32213534.
      View in: PubMed   Mentions:
    31. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020 03; 21(3):456-466. Martin-Broto J, Cruz J, Penel N, Le Cesne A, Hindi N, Luna P, Moura DS, Bernabeu D, de Alava E, Lopez-Guerrero JA, Dopazo J, Peña-Chilet M, Gutierrez A, Collini P, Karanian M, Redondo A, Lopez-Pousa A, Grignani G, Diaz-Martin J, Marcilla D, Fernandez-Serra A, Gonzalez-Aguilera C, Casali PG, Blay JY, Stacchiotti S. PMID: 32066540.
      View in: PubMed   Mentions:
    32. B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching. J Immunol. 2020 03 01; 204(5):1146-1157. Yan H, Fernandez M, Wang J, Wu S, Wang R, Lou Z, Moroney JB, Rivera CE, Taylor JR, Gan H, Zan H, Kolvaskyy D, Liu D, Casali P, Xu Z. PMID: 31932498.
      View in: PubMed   Mentions:
    33. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat Commun. 2020 01 02; 11(1):60. Sanchez HN, Moroney JB, Gan H, Shen T, Im JL, Li T, Taylor JR, Zan H, Casali P. PMID: 31896754.
      View in: PubMed   Mentions:
    34. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors. EClinicalMedicine. 2019 Dec; 17:100215. Callegaro D, Miceli R, Bonvalot S, Ferguson PC, Strauss DC, van Praag VVM, Levy A, Griffin AM, Hayes AJ, Stacchiotti S, Pèchoux CL, Smith MJ, Fiore M, Tos APD, Smith HG, Catton C, Szkandera J, Leithner A, van de Sande MAJ, Casali PG, Wunder JS, Gronchi A. PMID: 31891146.
      View in: PubMed   Mentions:
    35. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer. 2020 01 01; 126(1):98-104. Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S. PMID: 31536651.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Combination of PPAR? Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. Clin Cancer Res. 2019 12 15; 25(24):7565-7575. Frapolli R, Bello E, Ponzo M, Craparotta I, Mannarino L, Ballabio S, Marchini S, Carrassa L, Ubezio P, Porcu L, Brich S, Sanfilippo R, Casali PG, Gronchi A, Pilotti S, D'Incalci M. PMID: 31481505.
      View in: PubMed   Mentions:
    37. Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study. Eur J Cancer. 2019 10; 120:47-53. Hohenberger P, Bonvalot S, van Coevorden F, Rutkowski P, Stoeckle E, Olungu C, Litiere S, Wardelmann E, Gronchi A, Casali P. PMID: 31479947.
      View in: PubMed   Mentions:
    38. Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin. Br J Cancer. 2019 09; 121(6):464-473. Bello E, Brich S, Craparotta I, Mannarino L, Ballabio S, Gatta R, Marchini S, Carrassa L, Matteo C, Sanfilippo R, Gronchi A, Casali PG, Pilotti S, D'Incalci M, Frapolli R. PMID: 31409911.
      View in: PubMed   Mentions:
    39. Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft. Cancers (Basel). 2019 Jul 19; 11(7). Stacchiotti S, Zuco V, Tortoreto M, Cominetti D, Frezza AM, Percio S, Indio V, Barisella M, Monti V, Brich S, Astolfi A, Colombo C, Pasquali S, Folini M, Gounder MM, Pantaleo MA, Collini P, Dei Tos AP, Casali PG, Gronchi A, Zaffaroni N. PMID: 31331120.
      View in: PubMed   Mentions:
    40. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2019 09; 20(9):1252-1262. Stacchiotti S, Ferrari S, Redondo A, Hindi N, Palmerini E, Vaz Salgado MA, Frezza AM, Casali PG, Gutierrez A, Lopez-Pousa A, Grignani G, Italiano A, LeCesne A, Dumont S, Blay JY, Penel N, Bernabeu D, de Alava E, Karanian M, Morosi C, Brich S, Dagrada GP, Vallacchi V, Castelli C, Brenca M, Racanelli D, Maestro R, Collini P, Cruz J, Martin-Broto J. PMID: 31331701.
      View in: PubMed   Mentions:
    41. Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis. Ann Surg Oncol. 2019 Oct; 26(11):3535-3541. Nizri E, Fiore M, Barretta F, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Stacchiotti S, Casali PG, Miceli R, Gronchi A. PMID: 31313035.
      View in: PubMed   Mentions:
    42. Rare cancers: from centralized referral to networking. Ann Oncol. 2019 07 01; 30(7):1037-1038. Casali PG. PMID: 31046083.
      View in: PubMed   Mentions:
    43. Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas). Clin Cancer Res. 2019 09 01; 25(17):5295-5300. Sanfilippo R, Jones RL, Blay JY, Le Cesne A, Provenzano S, Antoniou G, Mir O, Fucà G, Fumagalli E, Bertulli R, Stacchiotti S, Brahmi M, Grosso F, Dufresne A, Hindi N, Sbaraglia M, Gronchi A, Collini P, Dei Tos AP, Casali PG. PMID: 31217199.
      View in: PubMed   Mentions:
    44. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas. J Pathol. 2019 09; 249(1):90-101. Brenca M, Stacchiotti S, Fassetta K, Sbaraglia M, Janjusevic M, Racanelli D, Polano M, Rossi S, Brich S, Dagrada GP, Collini P, Colombo C, Gronchi A, Astolfi A, Indio V, Pantaleo MA, Picci P, Casali PG, Dei Tos AP, Pilotti S, Maestro R. PMID: 31020999.
      View in: PubMed   Mentions:
    45. Management of complicated tumor response to tyrosine-kinase inhibitors in gastrointestinal stromal tumors. J Surg Oncol. 2019 Aug; 120(2):256-261. Tirotta F, Fumagalli E, Colombo C, Morosi C, Barisella M, Radaelli S, Frezza AM, Casali PG, Gronchi A, Fiore M. PMID: 31066052.
      View in: PubMed   Mentions:
    46. Shortages of inexpensive essential medicines. Lancet Oncol. 2019 05; 20(5):e224-e225. Vyas M, de Vries EGE, Casali PG, Tabernero J. PMID: 31006527.
      View in: PubMed   Mentions:
    47. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST. Genes Chromosomes Cancer. 2019 09; 58(9):636-642. Urbini M, Indio V, Tarantino G, Ravegnini G, Angelini S, Nannini M, Saponara M, Santini D, Ceccarelli C, Fiorentino M, Vincenzi B, Fumagalli E, Casali PG, Grignani G, Pession A, Ardizzoni A, Astolfi A, Pantaleo MA. PMID: 30887595.
      View in: PubMed   Mentions:
    48. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups. EClinicalMedicine. 2019 Mar; 9:35-43. Gronchi A, Hindi N, Cruz J, Blay JY, Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I, Sangalli C, Pérez Aguiar JL, Romero J, Morosi C, Sunyach MP, Sanfilippo R, Romagosa C, Ranchere-Vince D, Dei Tos AP, Casali PG, Martin-Broto J. PMID: 31143880.
      View in: PubMed   Mentions:
    49. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer. 2019 03; 109:51-60. Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A. PMID: 30690293.
      View in: PubMed   Mentions:
    50. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2019 01; 20(1):134-144. Martin-Broto J, Stacchiotti S, Lopez-Pousa A, Redondo A, Bernabeu D, de Alava E, Casali PG, Italiano A, Gutierrez A, Moura DS, Peña-Chilet M, Diaz-Martin J, Biscuola M, Taron M, Collini P, Ranchere-Vince D, Garcia Del Muro X, Grignani G, Dumont S, Martinez-Trufero J, Palmerini E, Hindi N, Sebio A, Dopazo J, Dei Tos AP, LeCesne A, Blay JY, Cruz J. PMID: 30578023.
      View in: PubMed   Mentions:
    51. Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis. J Surg Oncol. 2019 Mar; 119(3):318-323. Nizri E, Fiore M, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Morosi C, Stacchiotti S, Casali PG, Gronchi A. PMID: 30554403.
      View in: PubMed   Mentions:
    52. Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. Oncologist. 2019 07; 24(7):e536-e541. Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin-Broto J, Brahmi M, Collini P, Lorusso D, Raspagliesi F, Pantaleo MA, Vincenzi B, Fumagalli E, Gronchi A, Casali PG, Sanfilippo R. PMID: 30518617.
      View in: PubMed   Mentions:
    53. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. Eur J Cancer. 2019 01; 106:225-233. Stacchiotti S, Simeone N, Lo Vullo S, Morosi C, Greco FG, Gronchi A, Barisella M, Collini P, Zaffaroni N, Dagrada GP, Frezza AM, Mariani L, Casali PG. PMID: 30528807.
      View in: PubMed   Mentions:
    54. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. Eur J Cancer. 2018 12; 105:19-27. Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Le Pèchoux C, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Catton C, Casali PG, Wunder JS, Gronchi A. PMID: 30384013.
      View in: PubMed   Mentions:
    55. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). Cancer Treat Rev. 2018 Dec; 71:76-87. Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA. PMID: 30366202.
      View in: PubMed   Mentions:
    56. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv68-iv78. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. PMID: 29846513.
      View in: PubMed   Mentions:
    57. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv268-iv269. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. PMID: 30285214.
      View in: PubMed   Mentions: 29     Fields:    
    58. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv51-iv67. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. PMID: 29846498.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    59. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv79-iv95. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. PMID: 30285218.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    60. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv267. Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. PMID: 30188977.
      View in: PubMed   Mentions:
    61. Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study. Cancer. 2018 10 15; 124(20):4056-4063. Stacchiotti S, Morosi C, Lo Vullo S, Casale A, Palassini E, Frezza AM, Dinoi G, Messina A, Gronchi A, Cavalleri A, Venturelli E, Morelli D, Pilotti S, Collini P, Brich S, Tamborini E, Mariani L, Casali PG. PMID: 30216418.
      View in: PubMed   Mentions:
    62. Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study. Cancer Epidemiol. 2018 10; 56:146-153. Stiller CA, Botta L, Brewster DH, Ho VKY, Frezza AM, Whelan J, Casali PG, Trama A, Gatta G. PMID: 30179828.
      View in: PubMed   Mentions:
    63. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. JAMA Oncol. 2018 09 01; 4(9):e180219. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S. PMID: 29800950.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib. Ther Adv Med Oncol. 2018; 10:1758835918794623. Vincenzi B, Nannini M, Badalamenti G, Grignani G, Fumagalli E, Gasperoni S, D'Ambrosio L, Incorvaia L, Stellato M, Spalato Ceruso M, Napolitano A, Valeri S, Santini D, Tonini G, Casali PG, Dei Tos AP, Pantaleo MA. PMID: 30181783.
      View in: PubMed   Mentions:
    65. A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma. Br J Cancer. 2018 08; 119(5):565-571. Gadducci A, Grosso F, Scambia G, Raspagliesi F, Colombo N, Grignani G, Casali P, Sanfilippo R, Buonadonna A, Santoro A, Bruzzone M, Artioli G, Lorusso D, Biagioli E, Fossati R, Galli F, Negri E, Rulli E, Torri V, D'Incalci M. PMID: 30057406.
      View in: PubMed   Mentions:
    66. Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review. Anticancer Drugs. 2018 07; 29(6):589-595. Raimondi A, Colombo F, Pintarelli G, Morosi C, Renne SL, Frezza AM, Saponara M, Dei Tos AP, Mazzocchi A, Provenzano S, Casali PG, Stacchiotti S. PMID: 29668485.
      View in: PubMed   Mentions:
    67. 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma. ESMO Open. 2018; 3(4):e000390. Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG. PMID: 30018812.
      View in: PubMed   Mentions:
    68. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma. Int J Mol Sci. 2018 Jun 23; 19(7). Urbini M, Indio V, Astolfi A, Tarantino G, Renne SL, Pilotti S, Dei Tos AP, Maestro R, Collini P, Nannini M, Saponara M, Murrone L, Dagrada GP, Colombo C, Gronchi A, Pession A, Casali PG, Stacchiotti S, Pantaleo MA. PMID: 29937513.
      View in: PubMed   Mentions:
    69. Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group. Ann Surg. 2018 05; 267(5):959-964. MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Barretta F, Raut CP, Strauss DC. PMID: 28394870.
      View in: PubMed   Mentions:
    70. Networking in rare cancers: What was done, what's next. Eur J Surg Oncol. 2019 01; 45(1):16-18. Frezza AM, Trama A, Blay JY, Casali PG. PMID: 29685758.
      View in: PubMed   Mentions:
    71. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. Eur J Surg Oncol. 2018 09; 44(9):1384-1390. Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pienkowski A, Grimer R. PMID: 29650420.
      View in: PubMed   Mentions:
    72. Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2018 05; 19(5):639-648. Gelderblom H, Cropet C, Chevreau C, Boyle R, Tattersall M, Stacchiotti S, Italiano A, Piperno-Neumann S, Le Cesne A, Ferraresi V, Penel N, Duffaud F, Cassier P, Toulmonde M, Casali P, Taieb S, Guillemaut S, Metzger S, Pérol D, Blay JY. PMID: 29571946.
      View in: PubMed   Mentions:
    73. Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard? Ann Surg Oncol. 2018 Jun; 25(6):1536-1543. Fiore M, Ford S, Callegaro D, Sangalli C, Colombo C, Radaelli S, Frezza AM, Renne SL, Casali PG, Gronchi A. PMID: 29470819.
      View in: PubMed   Mentions:
    74. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial. Eur J Cancer. 2018 04; 93:28-36. Pasquali S, Colombo C, Pizzamiglio S, Verderio P, Callegaro D, Stacchiotti S, Martin Broto J, Lopez-Pousa A, Ferrari S, Poveda A, De Paoli A, Quagliuolo V, Jurado JC, Comandone A, Grignani G, De Sanctis R, Palassini E, Llomboart-Bosch A, Dei Tos AP, Casali PG, Picci P, Gronchi A. PMID: 29475197.
      View in: PubMed   Mentions:
    75. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018; 3(2):e000285. Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, Sonke GS, Martínez GA, Frenel JS, Karamouzis M, Strijbos M, Yazici O, Bossi P, Banerjee S, Troiani T, Eniu A, Ciardiello F, Tabernero J, Zielinski CC, Casali PG, Cardoso F, Douillard JY, Jezdic S, McGregor K, Bricalli G, Vyas M, Ilbawi A. PMID: 29464109.
      View in: PubMed   Mentions:
    76. Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor. Clin Sarcoma Res. 2017; 7:20. Provenzano S, Raimondi A, Bertulli RM, Colia V, Renne SL, Collini P, Dagrada G, Callegaro D, Fiore M, Greco FG, Casali PG. PMID: 29299229.
      View in: PubMed   Mentions:
    77. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017 Dec; 9(12):731-739. Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA. PMID: 29449894.
      View in: PubMed   Mentions:
    78. Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303. Ann Surg Oncol. 2017 Dec; 24(13):3872-3879. De Sanctis R, Giordano L, Colombo C, De Paoli A, Navarria P, Sangalli C, Buonadonna A, Sanfilippo R, Bertola G, Fiore M, Marrari A, Navarria F, Bertuzzi A, Casali PG, Basso S, Santoro A, Quagliuolo V, Gronchi A. PMID: 29043525.
      View in: PubMed   Mentions:
    79. Identification of IL-40, a Novel B Cell-Associated Cytokine. J Immunol. 2017 11 01; 199(9):3326-3335. Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, Villalta SA, Ushach I, Pone EJ, Casali P, Raffatellu M, Burkhardt AM, Hernandez-Ruiz M, Heller G, Hevezi PA, Zlotnik A. PMID: 28978694.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    80. Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation. J Vis Exp. 2017 09 20; (127). Sanchez HN, Shen T, Garcia D, Lai Z, Casali P, Zan H. PMID: 28994753.
      View in: PubMed   Mentions:
    81. Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2019 01; 45(1):31-39. Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A. PMID: 28985973.
      View in: PubMed   Mentions:
    82. High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma. Sarcoma. 2017; 2017:3739159. Colia V, Fumagalli E, Provenzano S, Bertulli R, Stacchiotti S, Morosi C, Collini P, Gronchi A, Casali PG, Sanfilippo R. PMID: 28947876.
      View in: PubMed   Mentions:
    83. Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma. Clin Sarcoma Res. 2017; 7:16. Colia V, Fiore M, Provenzano S, Fumagalli E, Bertulli R, Morosi C, Dei Tos AP, Barisella M, Gronchi A, Casali PG, Sanfilippo R. PMID: 28852467.
      View in: PubMed   Mentions:
    84. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist. 2018 01; 23(1):62-70. Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A. PMID: 28754721.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper. Eur J Cancer. 2017 09; 82:193-202. Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, van Poppel H, Wait S, Naredi P. PMID: 28692951.
      View in: PubMed   Mentions:
    86. Neoadjuvant treatment: a novel standard? Curr Opin Oncol. 2017 Jul; 29(4):253-259. Pasquali S, Palassini E, Stacchiotti S, Casali PG, Gronchi A. PMID: 28426465.
      View in: PubMed   Mentions:
    87. Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions. J Magn Reson Imaging. 2018 03; 47(3):829-840. Corino VDA, Montin E, Messina A, Casali PG, Gronchi A, Marchianò A, Mainardi LT. PMID: 28653477.
      View in: PubMed   Mentions:
    88. Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma. Br J Cancer. 2017 Jul 25; 117(3):340-346. Vincenzi B, Stacchiotti S, Collini P, Pantano F, Rabitti C, Perrone G, Iuliani M, Baldi A, Badalamenti G, Sanfilippo R, Santini D, Muda AO, Gronchi A, Casali P, Dei Tos AP, Tonini G. PMID: 28641307.
      View in: PubMed   Mentions:
    89. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol. 2017 Jun 01; 28(6):1230-1242. Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, Blay JY, Bolle S, Boriani S, Bruzzi P, Capanna R, Caraceni A, Casadei R, Colia V, Debus J, Delaney T, Desai A, Dileo P, Dijkstra S, Doglietto F, Flanagan A, Froelich S, Gardner PA, Gelderblom H, Gokaslan ZL, Haas R, Heery C, Hindi N, Hohenberger P, Hornicek F, Imai R, Jeys L, Jones RL, Kasper B, Kawai A, Krengli M, Leithner A, Logowska I, Martin Broto J, Mazzatenta D, Morosi C, Nicolai P, Norum OJ, Patel S, Penel N, Picci P, Pilotti S, Radaelli S, Ricchini F, Rutkowski P, Scheipl S, Sen C, Tamborini E, Thornton KA, Timmermann B, Torri V, Tunn PU, Uhl M, Yamada Y, Weber DC, Vanel D, Varga PP, Vleggeert-Lankamp CLA, Casali PG, Sommer J. PMID: 28184416.
      View in: PubMed   Mentions:
    90. Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue. Oncotarget. 2017 Sep 01; 8(36):60036-60045. Urbini M, Astolfi A, Indio V, Tarantino G, Serravalle S, Saponara M, Nannini M, Gronchi A, Fiore M, Maestro R, Brenca M, Dei Tos AP, Dagrada GP, Negri T, Pilotti S, Casali PG, Biasco G, Pession A, Stacchiotti S, Pantaleo MA. PMID: 28947952.
      View in: PubMed   Mentions:
    91. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017 06; 18(6):812-822. Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. PMID: 28499583.
      View in: PubMed   Mentions:
    92. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2017 07; 56(7):582-586. Urbini M, Astolfi A, Pantaleo MA, Serravalle S, Dei Tos AP, Picci P, Indio V, Sbaraglia M, Benini S, Righi A, Gambarotti M, Gronchi A, Colombo C, Dagrada GP, Pilotti S, Maestro R, Polano M, Saponara M, Tarantino G, Pession A, Biasco G, Casali PG, Stacchiotti S. PMID: 28383167.
      View in: PubMed   Mentions:
    93. Improving treatment results with reference centres for rare cancers: where do we stand? Eur J Cancer. 2017 05; 77:90-98. Ray-Coquard I, Pujade Lauraine E, Le Cesne A, Pautier P, Vacher Lavenue MC, Trama A, Casali P, Coindre JM, Blay JY. PMID: 28384534.
      View in: PubMed   Mentions:
    94. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels. J Clin Oncol. 2017 May 20; 35(15):1713-1720. Casali PG, Zalcberg J, Le Cesne A, Reichardt P, Blay JY, Lindner LH, Judson IR, Schöffski P, Leyvraz S, Italiano A, Grünwald V, Pousa AL, Kotasek D, Sleijfer S, Kerst JM, Rutkowski P, Fumagalli E, Hogendoorn P, Litière S, Marreaud S, van der Graaf W, Gronchi A, Verweij J. PMID: 28362562.
      View in: PubMed   Mentions:
    95. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. Eur J Cancer. 2017 05; 76:84-92. Stacchiotti S, Saponara M, Frapolli R, Tortoreto M, Cominetti D, Provenzano S, Negri T, Dagrada GP, Gronchi A, Colombo C, Vincenzi B, Badalamenti G, Zuco V, Renne SL, Collini P, Morosi C, Dei Tos AP, Bello E, Pilotti S, Casali PG, D'Incalci M, Zaffaroni N. PMID: 28284173.
      View in: PubMed   Mentions:
    96. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis. Cancer J. 2017 Mar/Apr; 23(2):86-91. Palassini E, Frezza AM, Mariani L, Lalli L, Colombo C, Fiore M, Messina A, Casale A, Morosi C, Collini P, Stacchiotti S, Casali PG, Gronchi A. PMID: 28410293.
      View in: PubMed   Mentions:
    97. How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clin Sarcoma Res. 2017; 7:4. Marchesi E, Cagnazzo C, Quattrini I, Leopardi MP, Villa C, Grignani G, D'Ambrosio L, Stacchiotti S, Casali PG, Picci P. PMID: 28261443.
      View in: PubMed   Mentions:
    98. Rad52 competes with Ku70/Ku86 for binding to S-region DSB ends to modulate antibody class-switch DNA recombination. Nat Commun. 2017 02 08; 8:14244. Zan H, Tat C, Qiu Z, Taylor JR, Guerrero JA, Shen T, Casali P. PMID: 28176781.
      View in: PubMed   Mentions:
    99. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer. 2017 06 01; 123(11):1971-1978. MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP, Gronchi A, Swallow CJ. PMID: 28152173.
      View in: PubMed   Mentions:
    100. Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST. Mol Cancer Res. 2017 05; 15(5):553-562. Pantaleo MA, Urbini M, Indio V, Ravegnini G, Nannini M, De Luca M, Tarantino G, Angelini S, Gronchi A, Vincenzi B, Grignani G, Colombo C, Fumagalli E, Gatto L, Saponara M, Ianni M, Paterini P, Santini D, Pirini MG, Ceccarelli C, Altimari A, Gruppioni E, Renne SL, Collini P, Stacchiotti S, Brandi G, Casali PG, Pinna AD, Astolfi A, Biasco G. PMID: 28130400.
      View in: PubMed   Mentions:
    101. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 2016; 1(6):e000142. Tabernero J, Vyas M, Giuliani R, Arnold D, Cardoso F, Casali PG, Cervantes A, Eggermont AMM, Eniu A, Jassem J, Pentheroudakis G, Peters S, Rauh S, Zielinski CC, Stahel RA, Voest E, Douillard JY, McGregor K, Ciardiello F. PMID: 28848668.
      View in: PubMed   Mentions:
    102. Advances and controversies in the management of soft tissue sarcomas. Future Oncol. 2017 Jan; 13(1s):3-11. Demetri GD, Blay JY, Casali PG. PMID: 27918199.
      View in: PubMed   Mentions:
    103. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review. Crit Rev Oncol Hematol. 2017 02; 110:94-105. Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Delgado Bolton R, Donati DM, Douis H, Haas R, Hogendoorn P, Kozhaeva O, Lavender V, Lovey J, Negrouk A, Pereira P, Roca P, de Lempdes GR, Saarto T, van Berck B, Vassal G, Wartenberg M, Yared W, Costa A, Naredi P. PMID: 28109409.
      View in: PubMed   Mentions:
    104. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open. 2016; 1(6):e000107. Morgan G, Lambertini M, Kourie HR, Amaral T, Argiles G, Banerjee S, Cardone C, Corral J, De Mattos-Arruda L, Öztürk A, Petrova M, Poulsen L, Strijbos M, Tyulyandina A, Vidra R, Califano R, de Azambuja E, Garrido Lopez P, Guarneri V, Reck M, Moiseyenko V, Martinelli E, Douillard JY, Stahel R, Voest E, Arnold D, Cardoso F, Casali P, Cervantes A, Eggermont AMM, Eniu A, Jassem J, Pentheroudakis G, Peters S, McGregor K, Rauh S, Zielinski CC, Ciardiello F, Tabernero J, Preusser M. PMID: 28255451.
      View in: PubMed   Mentions:
    105. (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair. Eur J Cancer. 2017 01; 70:1-11. Saponara M, Stacchiotti S, Casali PG, Gronchi A. PMID: 27866094.
      View in: PubMed   Mentions:
    106. Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework. Oncotarget. 2016 11 15; 7(46):75503-75517. Bozzi F, Brich S, Dagrada GP, Negri T, Conca E, Cortelazzi B, Belfiore A, Perrone F, Gualeni AV, Gloghini A, Cabras A, Brenca M, Maestro R, Zaffaroni N, Casali P, Bertulli R, Deraco M, Pilotti S. PMID: 27705913.
      View in: PubMed   Mentions:
    107. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study. Gynecol Oncol. 2017 Jan; 144(1):90-95. Raspagliesi F, Maltese G, Bogani G, Fucà G, Lepori S, De Iaco P, Perrone M, Scambia G, Cormio G, Bogliolo S, Bergamini A, Bifulco G, Casali PG, Lorusso D. PMID: 27817933.
      View in: PubMed   Mentions:
    108. Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis. Oncotarget. 2016 10 25; 7(43):69412-69419. Vincenzi B, Nannini M, Fumagalli E, Bronte G, Frezza AM, De Lisi D, Spalato Ceruso M, Santini D, Badalamenti G, Pantaleo MA, Russo A, Dei Tos AP, Casali P, Tonini G. PMID: 26416414.
      View in: PubMed   Mentions:
    109. Small Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus. J Immunol. 2016 11 15; 197(10):3792-3805. Lam T, Kulp DV, Wang R, Lou Z, Taylor J, Rivera CE, Yan H, Zhang Q, Wang Z, Zan H, Ivanov DN, Zhong G, Casali P, Xu Z. PMID: 27742832.
      View in: PubMed   Mentions:
    110. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Ann Oncol. 2016 12; 27(12):2283-2288. Gronchi A, Stacchiotti S, Verderio P, Ferrari S, Martin Broto J, Lopez-Pousa A, Llombart-Bosch A, Dei Tos AP, Collini P, Jurado JC, De Paoli A, Donati DM, Poveda A, Quagliuolo V, Comandone A, Grignani G, Morosi C, Messina A, De Sanctis R, Bottelli S, Palassini E, Casali PG, Picci P. PMID: 27733375.
      View in: PubMed   Mentions:
    111. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open. 2016; 1(5):e000097. Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y. PMID: 27843641.
      View in: PubMed   Mentions:
    112. Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone. Clin Sarcoma Res. 2016; 6(1):15. Gaston CL, Grimer RJ, Parry M, Stacchiotti S, Dei Tos AP, Gelderblom H, Ferrari S, Baldi GG, Jones RL, Chawla S, Casali P, LeCesne A, Blay JY, Dijkstra SP, Thomas DM, Rutkowski P. PMID: 27651889.
      View in: PubMed   Mentions:
    113. Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment. J Invest Dermatol. 2017 02; 137(2):484-493. Tazzari M, Indio V, Vergani B, De Cecco L, Rini F, Negri T, Camisaschi C, Fiore M, Stacchiotti S, Dagrada GP, Casali PG, Gronchi A, Astolfi A, Pantaleo MA, Villa A, Lombardo C, Arienti F, Pilotti S, Rivoltini L, Castelli C. PMID: 27608549.
      View in: PubMed   Mentions:
    114. Solitary fibrous tumour presenting with a single bone metastasis: report of six cases and literature review. Clin Sarcoma Res. 2016; 6(1):16. Colia V, Provenzano S, Morosi C, Collini P, Renne SL, Dagrada PG, Sangalli C, Dei Tos AP, Marrari A, Casali PG, Stacchiotti S. PMID: 27588167.
      View in: PubMed   Mentions:
    115. Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database. Ann Surg Oncol. 2016 09; 23(9):2735-44. Stacchiotti S, Provenzano S, Dagrada G, Negri T, Brich S, Basso U, Brunello A, Grosso F, Galli L, Palassini E, Libertini M, Colia V, Gronchi A, Dei Tos AP, Crippa F, Morosi C, Pilotti S, Casali PG. PMID: 27334221.
      View in: PubMed   Mentions:
    116. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss. Mol Cancer Res. 2016 09; 14(9):820-9. Stacchiotti S, Astolfi A, Gronchi A, Fontana A, Pantaleo MA, Negri T, Brenca M, Tazzari M, Urbini M, Indio V, Colombo C, Radaelli S, Brich S, Dei Tos AP, Casali PG, Castelli C, Dagrada GP, Pilotti S, Maestro R. PMID: 27256159.
      View in: PubMed   Mentions:
    117. Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers. Spine (Phila Pa 1976). 2016 Jun; 41(12):1049-1057. Radaelli S, Stacchiotti S, Ruggieri P, Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L, Boriani S, Gronchi A, Picci P. PMID: 27054448.
      View in: PubMed   Mentions:
    118. Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy. Gynecol Oncol. 2016 Jul; 142(1):95-101. Ray-Coquard I, Rizzo E, Blay JY, Casali P, Judson I, Hansen AK, Lindner LH, Dei Tos AP, Gelderblom H, Marreaud S, Litière S, Rutkowski P, Hohenberger P, Gronchi A, van der Graaf WT. PMID: 27208537.
      View in: PubMed   Mentions:
    119. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Surg Oncol. 2016 Sep; 25(3):125-31. Radaelli S, Fiore M, Colombo C, Ford S, Palassini E, Sanfilippo R, Stacchiotti S, Sangalli C, Morosi C, Casali PG, Gronchi A. PMID: 27566012.
      View in: PubMed   Mentions:
    120. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016 May; 263(5):1002-9. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP. PMID: 26727100.
      View in: PubMed   Mentions:
    121. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016 05; 17(5):671-80. Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Pechoux CL, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Mariani L, Wunder JS, Pollock RE, Casali PG, Gronchi A. PMID: 27068860.
      View in: PubMed   Mentions:
    122. External validation of a multi-institutional retroperitoneal sarcoma nomogram. Cancer. 2016 May 01; 122(9):1417-24. Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Casali PG, Haas RL, Hayes AJ, Honore C, Cannell AJ, Jakob J, Szacht M, Fairweather M, Pollock RE, Bonvalot S, Gronchi A. PMID: 26916507.
      View in: PubMed   Mentions:
    123. Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma. Rep Pract Oncol Radiother. 2016 Jul-Aug; 21(4):361-9. Colia V, Provenzano S, Hindi N, Casali PG, Stacchiotti S. PMID: 27330421.
      View in: PubMed   Mentions:
    124. Editorial: Epigenetics of B Cells and Antibody Responses. Front Immunol. 2015; 6:656. Zan H, Casali P. PMID: 26793194.
      View in: PubMed   Mentions:
    125. Genome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation. Front Immunol. 2015; 6:627. Shen T, Sanchez HN, Zan H, Casali P. PMID: 26697020.
      View in: PubMed   Mentions:
    126. Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response. Front Immunol. 2015; 6:631. Zan H, Casali P. PMID: 26697022.
      View in: PubMed   Mentions:
    127. Adjuvant Imatinib for GI Stromal Tumors: When and For How Long? J Clin Oncol. 2016 Jan 20; 34(3):215-8. Benjamin RS, Casali PG. PMID: 26644523.
      View in: PubMed   Mentions:
    128. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis. Eur J Cancer. 2015 Dec; 51(18):2800-7. Fiore M, Colombo C, Radaelli S, Callegaro D, Palassini E, Barisella M, Morosi C, Baldi GG, Stacchiotti S, Casali PG, Gronchi A. PMID: 26602014.
      View in: PubMed   Mentions:
    129. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. J Clin Oncol. 2015 Dec 20; 33(36):4276-83. Casali PG, Le Cesne A, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Adenis A, Hartmann JT, Duffaud F, Goldstein D, Broto JM, Gronchi A, Dei Tos AP, Marréaud S, van der Graaf WT, Zalcberg JR, Litière S, Blay JY. PMID: 26573069.
      View in: PubMed   Mentions:
    130. Regulation of B Cell Differentiation by Intracellular Membrane-Associated Proteins and microRNAs: Role in the Antibody Response. Front Immunol. 2015; 6:537. Lou Z, Casali P, Xu Z. PMID: 26579118.
      View in: PubMed   Mentions:
    131. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide. J Clin Oncol. 2015 Nov 01; 33(31):3628-34. Palassini E, Ferrari S, Verderio P, De Paoli A, Martin Broto J, Quagliuolo V, Comandone A, Sangalli C, Palmerini E, Lopez-Pousa A, De Sanctis R, Bottelli S, Libertini M, Picci P, Casali PG, Gronchi A. PMID: 26351345.
      View in: PubMed   Mentions:
    132. Imatinib in advanced chordoma: A retrospective case series analysis. Eur J Cancer. 2015 Nov; 51(17):2609-14. Hindi N, Casali PG, Morosi C, Messina A, Palassini E, Pilotti S, Tamborini E, Radaelli S, Gronchi A, Stacchiotti S. PMID: 26283036.
      View in: PubMed   Mentions:
    133. Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP). Clin Cancer Res. 2016 Feb 15; 22(4):837-46. Stacchiotti S, Pantaleo MA, Negri T, Astolfi A, Tazzari M, Dagrada GP, Urbini M, Indio V, Maestro R, Gronchi A, Fiore M, Dei Tos AP, Conca E, Palassini E, Vincenzi B, Grosso F, Pilotti S, Castelli C, Casali PG. PMID: 26261104.
      View in: PubMed   Mentions:
    134. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours. Eur J Cancer. 2015 Nov; 51(16):2423-33. Barrios CH, Blackstein ME, Blay JY, Casali PG, Chacon M, Gu J, Kang YK, Nishida T, Purkayastha D, Woodman RC, Reichardt P. PMID: 26248685.
      View in: PubMed   Mentions:
    135. Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network. Anticancer Drugs. 2015 Jul; 26(6):678-81. Sanfilippo R, Dileo P, Blay JY, Constantinidou A, Le Cesne A, Benson C, Vizzini L, Contu M, Baldi GG, Dei Tos AP, Casali PG. PMID: 25763543.
      View in: PubMed   Mentions:
    136. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. Am J Surg Pathol. 2015 Jul; 39(7):922-30. Rossi S, Gasparotto D, Miceli R, Toffolatti L, Gallina G, Scaramel E, Marzotto A, Boscato E, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Mariani L, Amore P, Gronchi A, Casali PG, Maestro R, Dei Tos AP. PMID: 25970686.
      View in: PubMed   Mentions:
    137. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma. Br J Surg. 2015 Aug; 102(9):1079-87. Callegaro D, Miceli R, Brunelli C, Colombo C, Sanfilippo R, Radaelli S, Casali PG, Caraceni A, Gronchi A, Fiore M. PMID: 26041724.
      View in: PubMed   Mentions:
    138. Hope in cancer patients: the relational domain as a crucial factor. Tumori. 2015 Jul-Aug; 101(4):447-54. Proserpio T, Ferrari A, Lo Vullo S, Massimino M, Clerici CA, Veneroni L, Bresciani C, Casali PG, Ferrari M, Bossi P, Galmozzi G, Pierantozzi A, Licitra L, Marceglia S, Mariani L. PMID: 26045106.
      View in: PubMed   Mentions:
    139. Specialized teams or specialist networks for rare cancers? Eur J Surg Oncol. 2015 Sep; 41(9):1115-7. Sandrucci S, Gatta G, Trama A, Dei Tos AP, Casali PG. PMID: 25936223.
      View in: PubMed   Mentions:
    140. An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again. Ann Oncol. 2015 May; 26(5):829-832. Dittrich C, Negrouk A, Casali PG. PMID: 25802239.
      View in: PubMed   Mentions:
    141. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. Eur J Cancer. 2015 May; 51(7):852-60. Lee CK, Goldstein D, Gibbs E, Joensuu H, Zalcberg J, Verweij J, Casali PG, Maki RG, Cioffi A, Mcarthur G, Lord SJ, Yip D, Kanjanapan Y, Rutkowski P. PMID: 25801699.
      View in: PubMed   Mentions:
    142. Response of conventional chondrosarcoma to gemcitabine alone: a case report. Clin Sarcoma Res. 2015; 5:9. Provenzano S, Hindi N, Morosi C, Ghilardi M, Collini P, Casali PG, Stacchiotti S. PMID: 25793102.
      View in: PubMed   Mentions:
    143. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015 Apr 01; 194(7):3065-78. Pone EJ, Lam T, Lou Z, Wang R, Chen Y, Liu D, Edinger AL, Xu Z, Casali P. PMID: 25740947.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    144. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma. Am J Surg Pathol. 2015 Mar; 39(3):383-93. Gronchi A, Collini P, Miceli R, Valeri B, Renne SL, Dagrada G, Fiore M, Sanfilippo R, Barisella M, Colombo C, Morosi C, Stacchiotti S, Casali PG, Dei Tos AP, Pilotti S. PMID: 25581729.
      View in: PubMed   Mentions:
    145. Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future. Oncology. 2015; 89(1):1-13. Blay JY, Casali PG, Dei Tos AP, Le Cesne A, Reichardt P. PMID: 25720422.
      View in: PubMed   Mentions:
    146. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report. BMC Cancer. 2015 Feb 14; 15:58. Tazzari M, Palassini E, Vergani B, Villa A, Rini F, Negri T, Colombo C, Crippa F, Morosi C, Casali PG, Pilotti S, Stacchiotti S, Rivoltini L, Castelli C. PMID: 25880253.
      View in: PubMed   Mentions:
    147. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses. Autoimmunity. 2015 Feb; 48(1):1-12. Pone EJ, Lou Z, Lam T, Greenberg ML, Wang R, Xu Z, Casali P. PMID: 25536171.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    148. Understanding Deviations from Clinical Practice Guidelines in Adult Soft Tissue Sarcoma. Stud Health Technol Inform. 2015; 216:280-4. Goldbraich E, Waks Z, Farkash A, Monti M, Torresani M, Bertulli R, Casali PG, Carmeli B. PMID: 26262055.
      View in: PubMed   Mentions:
    149. Adjuvant chemotherapy for soft tissue sarcoma. Am Soc Clin Oncol Educ Book. 2015; e629-33. Casali PG. PMID: 25993233.
      View in: PubMed   Mentions:
    150. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. Eur J Cancer. 2015 Jan; 51(2):186-92. Colombo C, Miceli R, Le Péchoux C, Palassini E, Honoré C, Stacchiotti S, Mir O, Casali PG, Dômont J, Fiore M, Le Cesne A, Gronchi A, Bonvalot S. PMID: 25500145.
      View in: PubMed   Mentions:
    151. Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. Lancet Oncol. 2015 Jan; 16(1):98-107. Grignani G, Palmerini E, Ferraresi V, D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y, Sangiolo D, Marchesi E, Capozzi F, Biagini R, Gambarotti M, Fagioli F, Casali PG, Picci P, Ferrari S, Aglietta M. PMID: 25498219.
      View in: PubMed   Mentions:
    152. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors. Eur J Cancer. 2015 Jan; 51(2):210-7. Palmerini E, Staals EL, Maki RG, Pengo S, Cioffi A, Gambarotti M, Picci P, Daolio PA, Parafioriti A, Morris C, Antonescu CR, Gronchi A, Casali PG, Donati DM, Ferrari S, Stacchiotti S. PMID: 25465190.
      View in: PubMed   Mentions:
    153. High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma. Clin Sarcoma Res. 2014; 4(1):16. Sanfilippo R, Bertulli R, Marrari A, Fumagalli E, Pilotti S, Morosi C, Messina A, Dei Tos AP, Gronchi A, Casali PG. PMID: 25628856.
      View in: PubMed   Mentions:
    154. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. J Immunol. 2014 Dec 15; 193(12):5933-50. White CA, Pone EJ, Lam T, Tat C, Hayama KL, Li G, Zan H, Casali P. PMID: 25392531.
      View in: PubMed   Mentions:
    155. Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center. Eur J Surg Oncol. 2014 Dec; 40(12):1662-70. Morosi C, Stacchiotti S, Marchianò A, Bianchi A, Radaelli S, Sanfilippo R, Colombo C, Richardson C, Collini P, Barisella M, Casali PG, Gronchi A, Fiore M. PMID: 25454827.
      View in: PubMed   Mentions:
    156. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2015 May; 22(5):1447-54. Gronchi A, Miceli R, Allard MA, Callegaro D, Le Péchoux C, Fiore M, Honoré C, Sanfilippo R, Coppola S, Stacchiotti S, Terrier P, Casali PG, Le Cesne A, Mariani L, Colombo C, Bonvalot S. PMID: 25300609.
      View in: PubMed   Mentions:
    157. Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper. Ann Oncol. 2015 Feb; 26(2):300-6. Casali PG, Bruzzi P, Bogaerts J, Blay JY. PMID: 25274616.
      View in: PubMed   Mentions:
    158. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. Eur J Cancer. 2014 Nov; 50(17):3021-8. Stacchiotti S, Tortoreto M, Baldi GG, Grignani G, Toss A, Badalamenti G, Cominetti D, Morosi C, Dei Tos AP, Festinese F, Fumagalli E, Provenzano S, Gronchi A, Pennacchioli E, Negri T, Dagrada GP, Spagnuolo RD, Pilotti S, Casali PG, Zaffaroni N. PMID: 25269954.
      View in: PubMed   Mentions:
    159. Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome. Eur J Hum Genet. 2015 Jun; 23(6):817-23. Angelini S, Ravegnini G, Nannini M, Bermejo JL, Musti M, Pantaleo MA, Fumagalli E, Venturoli N, Palassini E, Consolini N, Casali PG, Biasco G, Hrelia P. PMID: 25227144.
      View in: PubMed   Mentions:
    160. Identification of a gene expression driven progression pathway in myxoid liposarcoma. Oncotarget. 2014 Aug 15; 5(15):5965-77. De Cecco L, Negri T, Brich S, Mauro V, Bozzi F, Dagrada G, Disciglio V, Sanfilippo R, Gronchi A, D'Incalci M, Casali PG, Canevari S, Pierotti MA, Pilotti S. PMID: 25115389.
      View in: PubMed   Mentions:
    161. Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy. Br J Cancer. 2014 Sep 23; 111(7):1350-62. Tazzari M, Negri T, Rini F, Vergani B, Huber V, Villa A, Dagrada P, Colombo C, Fiore M, Gronchi A, Stacchiotti S, Casali PG, Pilotti S, Rivoltini L, Castelli C. PMID: 25101565.
      View in: PubMed   Mentions:
    162. Risks of the new EU Data Protection Regulation: an ESMO position paper endorsed by the European oncology community. Ann Oncol. 2014 Aug; 25(8):1458-61. Casali PG. PMID: 25063817.
      View in: PubMed   Mentions:
    163. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. Ann Oncol. 2015 May; 26(5):865-872. Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. PMID: 25070543.
      View in: PubMed   Mentions:
    164. Type II Toxoplasma gondii induction of CD40 on infected macrophages enhances interleukin-12 responses. Infect Immun. 2014 Oct; 82(10):4047-55. Morgado P, Sudarshana DM, Gov L, Harker KS, Lam T, Casali P, Boyle JP, Lodoen MB. PMID: 25024369.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    165. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol. 2014 Sep; 25(9):1673-1678. Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY, Eggermont A, Eniu A, McGregor K, Peters S, Piccart M, Popescu R, Van Cutsem E, Zielinski C, Stahel R. PMID: 24950979.
      View in: PubMed   Mentions:
    166. MicroRNAs in lupus. Autoimmunity. 2014 Jun; 47(4):272-85. Zan H, Tat C, Casali P. PMID: 24826805.
      View in: PubMed   Mentions:
    167. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg. 2014 May; 259(5):973-8. Fiore M, Coppola S, Cannell AJ, Colombo C, Bertagnolli MM, George S, Le Cesne A, Gladdy RA, Casali PG, Swallow CJ, Gronchi A, Bonvalot S, Raut CP. PMID: 24477160.
      View in: PubMed   Mentions:
    168. Activity of sunitinib in extraskeletal myxoid chondrosarcoma. Eur J Cancer. 2014 Jun; 50(9):1657-64. Stacchiotti S, Pantaleo MA, Astolfi A, Dagrada GP, Negri T, Dei Tos AP, Indio V, Morosi C, Gronchi A, Colombo C, Conca E, Toffolatti L, Tazzari M, Crippa F, Maestro R, Pilotti S, Casali PG. PMID: 24703573.
      View in: PubMed   Mentions:
    169. Rare cancers: work in progress in Europe. Ann Oncol. 2014 Apr; 25(4):914. Casali PG. PMID: 24667726.
      View in: PubMed   Mentions:
    170. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation. Histopathology. 2014 Jun; 64(7):1014-26. Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali PG, Perrone F, Tamborini E, Pellegrinelli A, Gherardi G, Arrigoni G, Collini P, Testi A, De Paoli E, Aiello A, Pilotti S, Pelosi G. PMID: 24898918.
      View in: PubMed   Mentions:
    171. Emerging therapies for adult soft tissue sarcoma. Expert Rev Anticancer Ther. 2014 Jun; 14(6):689-704. Radaelli S, Stacchiotti S, Casali PG, Gronchi A. PMID: 24555529.
      View in: PubMed   Mentions:
    172. Successes and limitations of targeted cancer therapy in gastrointestinal stromal tumors. Prog Tumor Res. 2014; 41:51-61. Casali PG. PMID: 24727986.
      View in: PubMed   Mentions:
    173. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol. 2014 Apr; 40(4):412-9. Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A. PMID: 24491288.
      View in: PubMed   Mentions:
    174. Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study. Clin Sarcoma Res. 2013 Dec 18; 3(1):16. Stacchiotti S, Dagrada GP, Sanfilippo R, Negri T, Vittimberga I, Ferrari S, Grosso F, Apice G, Tricomi M, Colombo C, Gronchi A, Dei Tos AP, Pilotti S, Casali PG. PMID: 24345066.
      View in: PubMed   Mentions:
    175. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol. 2014 Jan; 25(1):9-15. Popescu RA, Schäfer R, Califano R, Eckert R, Coleman R, Douillard JY, Cervantes A, Casali PG, Sessa C, Van Cutsem E, de Vries E, Pavlidis N, Fumasoli K, Wörmann B, Samonigg H, Cascinu S, Cruz Hernández JJ, Howard AJ, Ciardiello F, Stahel RA, Piccart M. PMID: 24335854.
      View in: PubMed   Mentions:
    176. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 2014 Mar; 25(3):578-583. Gronchi A, Colombo C, Le Péchoux C, Dei Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali PG, Stoeckle E, Gherlinzoni F, Meeus P, Mussi C, Gouin F, Duffaud F, Fiore M, Bonvalot S. PMID: 24325833.
      View in: PubMed   Mentions:
    177. Policy statement on multidisciplinary cancer care. Eur J Cancer. 2014 Feb; 50(3):475-80. Borras JM, Albreht T, Audisio R, Briers E, Casali P, Esperou H, Grube B, Hamoir M, Henning G, Kelly J, Knox S, Nabal M, Pierotti M, Lombardo C, van Harten W, Poston G, Prades J, Sant M, Travado L, Valentini V, van de Velde C, van den Bogaert S, van den Bulcke M, van Hoof E, van den Neucker I, Wilson R. PMID: 24321260.
      View in: PubMed   Mentions:
    178. Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. Eur J Cancer. 2014 Mar; 50(4):784-92. Gronchi A, De Paoli A, Dani C, Merlo DF, Quagliuolo V, Grignani G, Bertola G, Navarria P, Sangalli C, Buonadonna A, De Sanctis R, Sanfilippo R, Dei Tos AP, Stacchiotti S, Giorello L, Fiore M, Bruzzi P, Casali PG. PMID: 24316063.
      View in: PubMed   Mentions:
    179. Scaffold functions of 14-3-3 adaptors in B cell immunoglobulin class switch DNA recombination. PLoS One. 2013; 8(11):e80414. Lam T, Thomas LM, White CA, Li G, Pone EJ, Xu Z, Casali P. PMID: 24282540.
      View in: PubMed   Mentions:
    180. Mode of action of trabectedin in myxoid liposarcomas. Oncogene. 2014 Oct 30; 33(44):5201-10. Di Giandomenico S, Frapolli R, Bello E, Uboldi S, Licandro SA, Marchini S, Beltrame L, Brich S, Mauro V, Tamborini E, Pilotti S, Casali PG, Grosso F, Sanfilippo R, Gronchi A, Mantovani R, Gatta R, Galmarini CM, Sousa-Faro JM, D'Incalci M. PMID: 24213580.
      View in: PubMed   Mentions:
    181. Combinatorial H3K9acS10ph histone modification in IgH locus S regions targets 14-3-3 adaptors and AID to specify antibody class-switch DNA recombination. Cell Rep. 2013 Nov 14; 5(3):702-714. Li G, White CA, Lam T, Pone EJ, Tran DC, Hayama KL, Zan H, Xu Z, Casali P. PMID: 24209747.
      View in: PubMed   Mentions:
    182. MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study. . 2014 Jan; 13(1):249-59. Martin-Broto J, Gutierrez AM, Ramos RF, Lopez-Guerrero JA, Ferrari S, Stacchiotti S, Picci P, Calabuig S, Collini P, Gambarotti M, Bague S, Dei Tos AP, Palassini E, Luna P, Cruz J, Cubedo R, Martinez-Trufero J, Poveda A, Casali PG, Fernandez-Serra A, Lopez-Pousa A, Gronchi A. PMID: 24145283.
      View in: PubMed   Mentions:
    183. Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS. Hematol Oncol Clin North Am. 2013 Oct; 27(5):1049-61. Stacchiotti S, Marrari A, Dei Tos AP, Casali PG. PMID: 24093175.
      View in: PubMed   Mentions:
    184. Adjuvant therapy for high-risk soft tissue sarcoma in the adult. Curr Treat Options Oncol. 2013 Sep; 14(3):415-24. Gronchi A, Casali PG. PMID: 23775297.
      View in: PubMed   Mentions:
    185. Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma. Future Oncol. 2014 Jan; 10(1):59-68. Blay JY, Casali P, Nieto A, Tanovic A, Le Cesne A. PMID: 23987833.
      View in: PubMed   Mentions:
    186. TSPAN33 is a novel marker of activated and malignant B cells. Clin Immunol. 2013 Dec; 149(3):388-99. Luu VP, Hevezi P, Vences-Catalan F, Maravillas-Montero JL, White CA, Casali P, Llorente L, Jakez-Ocampo J, Lima G, Vilches-Cisneros N, Flores-Gutiérrez JP, Santos-Argumedo L, Zlotnik A. PMID: 24211713.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    187. Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clin Cancer Res. 2013 Sep 15; 19(18):5192-201. Stacchiotti S, Tortoreto M, Bozzi F, Tamborini E, Morosi C, Messina A, Libertini M, Palassini E, Cominetti D, Negri T, Gronchi A, Pilotti S, Zaffaroni N, Casali PG. PMID: 23888069.
      View in: PubMed   Mentions:
    188. Induction of activation-induced cytidine deaminase-targeting adaptor 14-3-3γ is mediated by NF-κB-dependent recruitment of CFP1 to the 5'-CpG-3'-rich 14-3-3γ promoter and is sustained by E2A. J Immunol. 2013 Aug 15; 191(4):1895-906. Mai T, Pone EJ, Li G, Lam TS, Moehlman J, Xu Z, Casali P. PMID: 23851690.
      View in: PubMed   Mentions:
    189. Myxoid liposarcoma and the mammalian target of rapamycin pathway. Curr Opin Oncol. 2013 Jul; 25(4):379-83. Sanfilippo R, Dei Tos AP, Casali PG. PMID: 23673410.
      View in: PubMed   Mentions:
    190. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013 Sep; 20(9):2937-43. Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F. PMID: 23760587.
      View in: PubMed   Mentions:
    191. The intriguing patterns of tumor response to trabectedin. Expert Rev Anticancer Ther. 2013 Jun; 13(6 Suppl 1):21-4. Sanfilippo R, Casali PG. PMID: 23638727.
      View in: PubMed   Mentions:
    192. Localised thoracic sarcomas: outcome improvement over time at a single institution. Eur J Cancer. 2013 Aug; 49(12):2689-97. Duranti L, Gronchi A, Stacchiotti S, Fiore M, Casali PG, Collini P, Pelosi G, Galeone C, Pastorino U. PMID: 23683891.
      View in: PubMed   Mentions:
    193. Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib. Clin Sarcoma Res. 2013 May 13; 3(1):8. Stacchiotti S, Crippa F, Messina A, Pilotti S, Gronchi A, Blay JY, Casali PG. PMID: 23668619.
      View in: PubMed   Mentions:
    194. Epigenetics of the antibody response. Trends Immunol. 2013 Sep; 34(9):460-70. Li G, Zan H, Xu Z, Casali P. PMID: 23643790.
      View in: PubMed   Mentions:
    195. Response to chemotherapy of solitary fibrous tumour: a retrospective study. Eur J Cancer. 2013 Jul; 49(10):2376-83. Stacchiotti S, Libertini M, Negri T, Palassini E, Gronchi A, Fatigoni S, Poletti P, Vincenzi B, Dei Tos AP, Mariani L, Pilotti S, Casali PG. PMID: 23566418.
      View in: PubMed   Mentions:
    196. Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution. Ann Oncol. 2013 Aug; 24(8):2181-9. Mattavelli D, Miceli R, Radaelli S, Mattavelli F, Cantù G, Barisella M, Quattrone P, Stacchiotti S, Sangalli C, Casali PG, Gronchi A, Fiore M. PMID: 23562930.
      View in: PubMed   Mentions:
    197. Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol. 2013 Jul; 24(7):1931-1936. Stacchiotti S, Tamborini E, Lo Vullo S, Bozzi F, Messina A, Morosi C, Casale A, Crippa F, Conca E, Negri T, Palassini E, Marrari A, Palmerini E, Mariani L, Gronchi A, Pilotti S, Casali PG. PMID: 23559153.
      View in: PubMed   Mentions:
    198. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013; 3:4. Baldi GG, Stacchiotti S, Mauro V, Dei Tos AP, Gronchi A, Pastorino U, Duranti L, Provenzano S, Marrari A, Libertini M, Pilotti S, Casali PG. PMID: 23551825.
      View in: PubMed   Mentions:
    199. Improving methodology to go beyond histology in rare cancers. Lancet Oncol. 2013 Apr; 14(4):276-7. Casali PG. PMID: 23477834.
      View in: PubMed   Mentions:
    200. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell. 2013 Feb 11; 23(2):249-62. Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, Erba E, Uboldi S, Zucchetti M, Pasqualini F, Nebuloni M, van Rooijen N, Mortarini R, Beltrame L, Marchini S, Fuso Nerini I, Sanfilippo R, Casali PG, Pilotti S, Galmarini CM, Anichini A, Mantovani A, D'Incalci M, Allavena P. PMID: 23410977.
      View in: PubMed   Mentions:
    201. Regulation of Aicda expression and AID activity. Autoimmunity. 2013 Mar; 46(2):83-101. Zan H, Casali P. PMID: 23181381.
      View in: PubMed   Mentions:
    202. Analyzing the "CareGap": assessing gaps in adherence to clinical guidelines in adult soft tissue sarcoma. Stud Health Technol Inform. 2013; 186:46-50. Waks Z, Goldbraich E, Farkash A, Torresani M, Bertulli R, Restifo N, Locatelli P, Casali P, Carmeli B. PMID: 23542965.
      View in: PubMed   Mentions:
    203. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013 Jan 26; 381(9863):295-302. Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG. PMID: 23177515.
      View in: PubMed   Mentions:
    204. APRIL stimulates NF-κB-mediated HoxC4 induction for AID expression in mouse B cells. Cytokine. 2013 Feb; 61(2):608-13. Park SR, Kim PH, Lee KS, Lee SH, Seo GY, Yoo YC, Lee J, Casali P. PMID: 23178148.
      View in: PubMed   Mentions:
    205. Rev1 recruits ung to switch regions and enhances du glycosylation for immunoglobulin class switch DNA recombination. Cell Rep. 2012 Nov 29; 2(5):1220-32. Zan H, White CA, Thomas LM, Mai T, Li G, Xu Z, Zhang J, Casali P. PMID: 23140944.
      View in: PubMed   Mentions:
    206. Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy. Pharmacol Res. 2013 Feb; 68(1):1-6. Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, Fumagalli E, Palassini E, Saponara M, Di Battista M, Casali PG, Hrelia P, Cantelli-Forti G, Biasco G. PMID: 23127916.
      View in: PubMed   Mentions:
    207. Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy. Ann Oncol. 2013 Feb; 24(2):537-542. Penel N, Demetri GD, Blay JY, Cousin S, Maki RG, Chawla SP, Judson I, von Mehren M, Schöffski P, Verweij J, Casali P, Rodenhuis S, Schütte HJ, Cassar A, Gomez J, Nieto A, Zintl P, Pontes MJ, Le Cesne A. PMID: 23117071.
      View in: PubMed   Mentions:
    208. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013 Mar; 24(3):817-23. Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majò J, Martin J, Comandone A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Palassini E, Stacchiotti S, Ferrari S, Fiore M, Casali PG. PMID: 23110811.
      View in: PubMed   Mentions:
    209. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013 Feb; 49(3):684-95. Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG. PMID: 23079473.
      View in: PubMed   Mentions:
    210. Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib. Clin Sarcoma Res. 2012 Oct 11; 2(1):22. Stacchiotti S, Dagrada GP, Morosi C, Negri T, Romanini A, Pilotti S, Gronchi A, Casali PG. PMID: 23058004.
      View in: PubMed   Mentions:
    211. Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas. Ann Oncol. 2012 Sep; 23 Suppl 10:x167-9. Casali PG. PMID: 22987955.
      View in: PubMed   Mentions:
    212. Adjuvant therapy of gastrointestinal stromal tumors (GIST). Curr Treat Options Oncol. 2012 Sep; 13(3):277-84. Casali PG, Fumagalli E, Gronchi A. PMID: 22743760.
      View in: PubMed   Mentions:
    213. Adjuvant therapy in primary GIST: state-of-the-art. Ann Oncol. 2012 Nov; 23(11):2776-2781. Reichardt P, Blay JY, Boukovinas I, Brodowicz T, Broto JM, Casali PG, Decatris M, Eriksson M, Gelderblom H, Kosmidis P, Le Cesne A, Pousa AL, Schlemmer M, Verweij J, Joensuu H. PMID: 22831984.
      View in: PubMed   Mentions:
    214. A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas. Eur J Cancer. 2012 Nov; 48(16):3036-44. Le Cesne A, Cresta S, Maki RG, Blay JY, Verweij J, Poveda A, Casali PG, Balaña C, Schöffski P, Grosso F, Lardelli P, Nieto A, Alfaro V, Demetri GD. PMID: 22749255.
      View in: PubMed   Mentions:
    215. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol. 2012 Jun 25; 12(7):517-31. Xu Z, Zan H, Pone EJ, Mai T, Casali P. PMID: 22728528.
      View in: PubMed   Mentions:
    216. Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Clin Cancer Res. 2012 Aug 15; 18(16):4458-64. Cassier PA, Fumagalli E, Rutkowski P, Schöffski P, Van Glabbeke M, Debiec-Rychter M, Emile JF, Duffaud F, Martin-Broto J, Landi B, Adenis A, Bertucci F, Bompas E, Bouché O, Leyvraz S, Judson I, Verweij J, Casali P, Blay JY, Hohenberger P. PMID: 22718859.
      View in: PubMed   Mentions:
    217. Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol. 2012 Dec; 23(12):3171-3179. Stacchiotti S, Negri T, Libertini M, Palassini E, Marrari A, De Troia B, Gronchi A, Dei Tos AP, Morosi C, Messina A, Pilotti S, Casali PG. PMID: 22711763.
      View in: PubMed   Mentions:
    218. Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure. Clin Cancer Res. 2012 Jun 01; 18(11):3170-9. Demetri GD, Garrett CR, Schöffski P, Shah MH, Verweij J, Leyvraz S, Hurwitz HI, Pousa AL, Le Cesne A, Goldstein D, Paz-Ares L, Blay JY, McArthur GA, Xu QC, Huang X, Harmon CS, Tassell V, Cohen DP, Casali PG. PMID: 22661587.
      View in: PubMed   Mentions:
    219. B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front Biosci (Landmark Ed). 2012 Jun 01; 17:2594-615. Pone EJ, Xu Z, White CA, Zan H, Casali P. PMID: 22652800.
      View in: PubMed   Mentions:
    220. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012 Dec 01; 118(23):5857-66. Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, Martin J, Comandone A, Cruz J, Ferraro A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Casali PG, Gronchi A. PMID: 22605504.
      View in: PubMed   Mentions:
    221. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012 May 19; 379(9829):1879-86. van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P. PMID: 22595799.
      View in: PubMed   Mentions:
    222. Iron inhibits activation-induced cytidine deaminase enzymatic activity and modulates immunoglobulin class switch DNA recombination. J Biol Chem. 2012 Jun 15; 287(25):21520-9. Li G, Pone EJ, Tran DC, Patel PJ, Dao L, Xu Z, Casali P. PMID: 22556412.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    223. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease? Cancer. 2012 Nov 01; 118(21):5349-57. Colombo C, Miceli R, Collini P, Radaelli S, Palassini E, Stacchiotti S, Fiore M, Mariani L, Casali PG, Gronchi A. PMID: 22517186.
      View in: PubMed   Mentions:
    224. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. Nat Commun. 2012 Apr 03; 3:767. Pone EJ, Zhang J, Mai T, White CA, Li G, Sakakura JK, Patel PJ, Al-Qahtani A, Zan H, Xu Z, Casali P. PMID: 22473011.
      View in: PubMed   Mentions: 90     Fields:    Translation:AnimalsCells
    225. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy. J Cell Physiol. 2012 Apr; 227(4):1657-62. Vincenzi B, Santini D, Schiavon G, Frezza AM, Silletta M, Crucitti P, Casali P, Dei Tos AP, Rossi S, Rizzo S, Badalamenti G, Tomasino RM, Russo A, Butrynski JE, Tonini G. PMID: 21678421.
      View in: PubMed   Mentions:
    226. Phase II study of imatinib in advanced chordoma. J Clin Oncol. 2012 Mar 20; 30(9):914-20. Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, Bertuzzi A, Tamborini E, Pilotti S, Messina A, Spreafico C, Gronchi A, Amore P, Vinaccia V, Casali PG. PMID: 22331945.
      View in: PubMed   Mentions:
    227. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012 Mar 10; 30(8):850-6. Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R, Stacchiotti S, Dei Tos AP, De Paoli A, Longhi A, Poveda A, Quagliuolo V, Comandone A, Casali PG, Picci P. PMID: 22312103.
      View in: PubMed   Mentions:
    228. Automatic detection of inconsistencies between free text and coded data in Sarcoma discharge letters. Stud Health Technol Inform. 2012; 180:661-6. Rinott R, Torresani M, Bertulli R, Goldsteen A, Casali P, Carmeli B, Slonim N. PMID: 22874274.
      View in: PubMed   Mentions:
    229. Evicase: an evidence-based case structuring approach for personalized healthcare. Stud Health Technol Inform. 2012; 180:604-8. Carmeli B, Casali P, Goldbraich A, Goldsteen A, Kent C, Licitra L, Locatelli P, Restifo N, Rinott R, Sini E, Torresani M, Waks Z. PMID: 22874262.
      View in: PubMed   Mentions:
    230. Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib. Ann Surg Oncol. 2012 May; 19(5):1551-9. Italiano A, Cioffi A, Coco P, Maki RG, Schöffski P, Rutkowski P, Le Cesne A, Duffaud F, Adenis A, Isambert N, Bompas E, Blay JY, Casali P, Keohan ML, Toulmonde M, Antonescu CR, Debiec-Rychter M, Coindre JM, Bui B. PMID: 22065192.
      View in: PubMed   Mentions:
    231. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011 Nov; 35(11):1646-56. Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Toffolatti L, Laurino L, Mariani L, Vinaccia V, Gnocchi C, Gronchi A, Casali PG, Dei Tos AP. PMID: 21997685.
      View in: PubMed   Mentions:
    232. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. Genes Chromosomes Cancer. 2012 Feb; 51(2):111-26. Negri T, Brich S, Conca E, Bozzi F, Orsenigo M, Stacchiotti S, Alberghini M, Mauro V, Gronchi A, Dusio GF, Pelosi G, Picci P, Casali PG, Pierotti MA, Pilotti S. PMID: 22045652.
      View in: PubMed   Mentions:
    233. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011 Nov; 47(17):2493-511. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R. PMID: 22033323.
      View in: PubMed   Mentions:
    234. Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers. Gynecol Oncol. 2011 Dec; 123(3):553-6. Sanfilippo R, Grosso F, Jones RL, Banerjee S, Pilotti S, D'Incalci M, Dei Tos AP, Raspagliesi F, Judson I, Casali PG. PMID: 21917307.
      View in: PubMed   Mentions:
    235. Uterine sarcomas: a multidisciplinary challenge. Eur J Cancer. 2011 Sep; 47 Suppl 3:S326-7. Casali PG, Sanfilippo R. PMID: 21944001.
      View in: PubMed   Mentions:
    236. Systemic therapy options for unresectable and metastatic chordomas. Curr Oncol Rep. 2011 Aug; 13(4):323-30. Stacchiotti S, Casali PG. PMID: 21584646.
      View in: PubMed   Mentions:
    237. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol. 2012 Feb; 19(2):511-8. Fiore M, Colombo C, Locati P, Berselli M, Radaelli S, Morosi C, Casali PG, Gronchi A. PMID: 21792507.
      View in: PubMed   Mentions:
    238. A new journal... on spindle cells. Clin Sarcoma Res. 2011 Jul 25; 1(1):1. Casali PG, Dei Tos AP. PMID: 22613678.
      View in: PubMed   Mentions:
    239. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012 Apr; 23(4):1067-73. Gronchi A, Miceli R, Colombo C, Stacchiotti S, Collini P, Mariani L, Sangalli C, Radaelli S, Sanfilippo R, Fiore M, Casali PG. PMID: 21765179.
      View in: PubMed   Mentions:
    240. Medical oncology: the long-awaited prize of recognition. Ann Oncol. 2011 Aug; 22(8):1695-7. Casali PG. PMID: 21719645.
      View in: PubMed   Mentions:
    241. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4. Autoimmunity. 2011 Dec; 44(8):585-98. White CA, Seth Hawkins J, Pone EJ, Yu ES, Al-Qahtani A, Mai T, Zan H, Casali P. PMID: 21585311.
      View in: PubMed   Mentions:
    242. Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. Br J Cancer. 2011 May 24; 104(11):1686-90. Joensuu H, De Braud F, Grignagni G, De Pas T, Spitalieri G, Coco P, Spreafico C, Boselli S, Toffalorio F, Bono P, Jalava T, Kappeler C, Aglietta M, Laurent D, Casali PG. PMID: 21540861.
      View in: PubMed   Mentions:
    243. A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol. 2012 Feb; 23(2):508-16. Grignani G, Palmerini E, Dileo P, Asaftei SD, D'Ambrosio L, Pignochino Y, Mercuri M, Picci P, Fagioli F, Casali PG, Ferrari S, Aglietta M. PMID: 21527590.
      View in: PubMed   Mentions:
    244. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol. 2012 Feb; 23(2):501-8. Stacchiotti S, Palassini E, Sanfilippo R, Vincenzi B, Arena MG, Bochicchio AM, De Rosa P, Nuzzo A, Turano S, Morosi C, Dei Tos AP, Pilotti S, Casali PG. PMID: 21464156.
      View in: PubMed   Mentions:
    245. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. Int J Cancer. 2011 Oct 01; 129(7):1761-72. Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, Collini P, Keslair F, Morosi C, Gronchi A, Pilotti S, Casali PG. PMID: 21128251.
      View in: PubMed   Mentions:
    246. Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer. 2011 May; 47(7):1006-12. Schöffski P, Taron M, Jimeno J, Grosso F, Sanfilipio R, Casali PG, Le Cesne A, Jones RL, Blay JY, Poveda A, Maki RG, Nieto A, Tercero JC, Rosell R. PMID: 21376569.
      View in: PubMed   Mentions:
    247. Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study. Int J Cancer. 2011 Feb 15; 128(4):983-90. Dileo P, Pricl S, Tamborini E, Negri T, Stacchiotti S, Gronchi A, Posocco P, Laurini E, Coco P, Fumagalli E, Casali PG, Pilotti S. PMID: 20473908.
      View in: PubMed   Mentions:
    248. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma. Cancer. 2011 Aug 01; 117(15):3445-56. Italiano A, Laurand A, Laroche A, Casali P, Sanfilippo R, Le Cesne A, Judson I, Blay JY, Ray-Coquard I, Bui B, Coindre JM, Nieto A, Tercero JC, Jimeno J, Robert J, Pourquier P. PMID: 21287534.
      View in: PubMed   Mentions:
    249. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol. 2011 Jul; 22(7):1675-1681. Gronchi A, Miceli R, Colombo C, Collini P, Stacchiotti S, Olmi P, Mariani L, Bertulli R, Fiore M, Casali PG. PMID: 21242585.
      View in: PubMed   Mentions:
    250. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann Oncol. 2011 Jul; 22(7):1682-1690. Stacchiotti S, Negri T, Zaffaroni N, Palassini E, Morosi C, Brich S, Conca E, Bozzi F, Cassinelli G, Gronchi A, Casali PG, Pilotti S. PMID: 21242589.
      View in: PubMed   Mentions:
    251. Endonuclease G plays a role in immunoglobulin class switch DNA recombination by introducing double-strand breaks in switch regions. Mol Immunol. 2011 Jan; 48(4):610-22. Zan H, Zhang J, Al-Qahtani A, Pone EJ, White CA, Lee D, Yel L, Mai T, Casali P. PMID: 21111482.
      View in: PubMed   Mentions:
    252. A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-a or -ß: An Italian Sarcoma Group study. Cancer. 2011 Feb 15; 117(4):826-31. Grignani G, Palmerini E, Stacchiotti S, Boglione A, Ferraresi V, Frustaci S, Comandone A, Casali PG, Ferrari S, Aglietta M. PMID: 20925044.
      View in: PubMed   Mentions:
    253. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Am J Surg Pathol. 2010 Oct; 34(10):1480-91. Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Maestra R, Dei Tos AP. PMID: 20861712.
      View in: PubMed   Mentions:
    254. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2011 Mar; 18(3):720-5. Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E, Barisella M, Sangalli C, Mariani L, Casali PG, Gronchi A. PMID: 20878245.
      View in: PubMed   Mentions:
    255. Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation. J Biol Chem. 2010 Nov 26; 285(48):37797-810. Mai T, Zan H, Zhang J, Hawkins JS, Xu Z, Casali P. PMID: 20855884.
      View in: PubMed   Mentions:
    256. Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. Autoimmunity. 2010 Dec; 43(8):682-9. Zhang W, Dang S, Wang J, Nardi MA, Zan H, Casali P, Li Z. PMID: 20828249.
      View in: PubMed   Mentions:
    257. PML down-regulation in soft tissue sarcomas. J Cell Physiol. 2010 Sep; 224(3):644-8. Vincenzi B, Perrone G, Santini D, Grosso F, Silletta M, Frezza A, Rossi S, Russo A, Rabitti C, Gebbia N, Badalamenti G, Casali P, Muda AO, Dei Tos AP, Tonini G. PMID: 20578240.
      View in: PubMed   Mentions:
    258. 14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination. Nat Struct Mol Biol. 2010 Sep; 17(9):1124-35. Xu Z, Fulop Z, Wu G, Pone EJ, Zhang J, Mai T, Thomas LM, Al-Qahtani A, White CA, Park SR, Steinacker P, Li Z, Yates J, Herron B, Otto M, Zan H, Fu H, Casali P. PMID: 20729863.
      View in: PubMed   Mentions:
    259. Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors. Clin Cancer Res. 2010 Oct 15; 16(20):4958-67. Frapolli R, Tamborini E, Virdis E, Bello E, Tarantino E, Marchini S, Grosso F, Sanfilippo R, Gronchi A, Tercero JC, Peloso G, Casali P, Pilotti S, D'Incalci M. PMID: 20732964.
      View in: PubMed   Mentions:
    260. Fluorescence in situ hybridization analysis and immunophenotyping of c-Kit/PDGFRA and Bcl-2 expression in gastrointestinal stromal tumors. Anal Quant Cytol Histol. 2010 Aug; 32(4):225-33. Orsenigo M, Brich S, Riva C, Conca E, Bertulli R, Dileo P, Gronchi A, Casali PG, Pierotti MA, Tamborini E, Pilotti S. PMID: 21434524.
      View in: PubMed   Mentions:
    261. Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution. Ann Surg Oncol. 2010 Dec; 17(12):3229-33. Pennacchioli E, Fiore M, Collini P, Radaelli S, Dileo P, Stacchiotti S, Casali PG, Gronchi A. PMID: 20593242.
      View in: PubMed   Mentions:
    262. Trabectedin therapy for sarcomas. Curr Opin Oncol. 2010 Jul; 22(4):342-6. Casali PG, Sanfilippo R, D'Incalci M. PMID: 20489618.
      View in: PubMed   Mentions:
    263. Do rare cancers deserve specific strategies for cancer research? Lancet Oncol. 2010 Jun; 11(6):506-7. Casali PG. PMID: 20522374.
      View in: PubMed   Mentions:
    264. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010 Jun; 17(6):1507-14. Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, Bouzaiene H, Le Péchoux C, Casali PG, Le Cesne A, Fiore M, Gronchi A. PMID: 20393803.
      View in: PubMed   Mentions:
    265. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer. 2010 May 15; 116(10):2429-36. Ardoino I, Miceli R, Berselli M, Mariani L, Biganzoli E, Fiore M, Collini P, Stacchiotti S, Casali PG, Gronchi A. PMID: 20209615.
      View in: PubMed   Mentions:
    266. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May; 21 Suppl 5:v98-102. Casali PG, Blay JY. PMID: 20555113.
      View in: PubMed   Mentions:
    267. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. . 2010 May; 9(5):1286-97. Stacchiotti S, Negri T, Palassini E, Conca E, Gronchi A, Morosi C, Messina A, Pastorino U, Pierotti MA, Casali PG, Pilotti S. PMID: 20457621.
      View in: PubMed   Mentions:
    268. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May; 21 Suppl 5:v198-203. Casali PG, Blay JY. PMID: 20555081.
      View in: PubMed   Mentions:
    269. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res. 2010 Mar 15; 70(6):2235-44. Germano G, Frapolli R, Simone M, Tavecchio M, Erba E, Pesce S, Pasqualini F, Grosso F, Sanfilippo R, Casali PG, Gronchi A, Virdis E, Tarantino E, Pilotti S, Greco A, Nebuloni M, Galmarini CM, Tercero JC, Mantovani A, D'Incalci M, Allavena P. PMID: 20215499.
      View in: PubMed   Mentions:
    270. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010 Mar; 251(3):506-11. Gronchi A, Lo Vullo S, Colombo C, Collini P, Stacchiotti S, Mariani L, Fiore M, Casali PG. PMID: 20130465.
      View in: PubMed   Mentions:
    271. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Neuro Oncol. 2010 Aug; 12(8):776-89. Tamborini E, Virdis E, Negri T, Orsenigo M, Brich S, Conca E, Gronchi A, Stacchiotti S, Manenti G, Casali PG, Pierotti MA, Pilotti S. PMID: 20164240.
      View in: PubMed   Mentions:
    272. Tumor response to sunitinib malate observed in clear-cell sarcoma. Ann Oncol. 2010 May; 21(5):1130-1. Stacchiotti S, Grosso F, Negri T, Palassini E, Morosi C, Pilotti S, Gronchi A, Casali PG. PMID: 20093352.
      View in: PubMed   Mentions:
    273. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol. 2010; 30(1):1-29. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, Casali P. PMID: 20370617.
      View in: PubMed   Mentions:
    274. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2010 Jan; 17(1):211-9. Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P. PMID: 19847568.
      View in: PubMed   Mentions:
    275. International collaborations in cancer control and the Third International Cancer Control Congress. Tumori. 2009 Sep-Oct; 95(5):579-96. Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou JM, Bisanti L, Seniori Costantini A, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, Baili P. PMID: 19999949.
      View in: PubMed   Mentions:
    276. A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors. Clin Cancer Res. 2009 Sep 15; 15(18):5910-6. Demetri GD, Casali PG, Blay JY, von Mehren M, Morgan JA, Bertulli R, Ray-Coquard I, Cassier P, Davey M, Borghaei H, Pink D, Debiec-Rychter M, Cheung W, Bailey SM, Veronese ML, Reichardt A, Fumagalli E, Reichardt P. PMID: 19723647.
      View in: PubMed   Mentions:
    277. Translocation-related sarcomas. Semin Oncol. 2009 Aug; 36(4):312-23. Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D'Incalci M, Casali PG, Aglietta M, Alvegård T. PMID: 19664492.
      View in: PubMed   Mentions:
    278. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? Ann Oncol. 2010 Feb; 21(2):403-408. Mussi C, Ronellenfitsch U, Jakob J, Tamborini E, Reichardt P, Casali PG, Fiore M, Hohenberger P, Gronchi A. PMID: 19628568.
      View in: PubMed   Mentions:
    279. Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial. J Clin Oncol. 2009 Aug 20; 27(24):3969-74. Le Cesne A, Van Glabbeke M, Verweij J, Casali PG, Findlay M, Reichardt P, Issels R, Judson I, Schoffski P, Leyvraz S, Bui B, Hogendoorn PC, Sciot R, Blay JY. PMID: 19620483.
      View in: PubMed   Mentions:
    280. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009 Sep; 16(9):2587-93. Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péchoux C, Casali PG, Le Cesne A, Gronchi A, Bonvalot S. PMID: 19568815.
      View in: PubMed   Mentions:
    281. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009 Nov; 20(11):1886-94. Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG. PMID: 19570961.
      View in: PubMed   Mentions:
    282. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol. 2009 Aug; 20(8):1439-44. Grosso F, Sanfilippo R, Virdis E, Piovesan C, Collini P, Dileo P, Morosi C, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Pilotti S, Casali PG. PMID: 19465423.
      View in: PubMed   Mentions:
    283. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:137-9. Bielack S, Carrle D, Casali PG. PMID: 19454435.
      View in: PubMed   Mentions:
    284. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:132-6. Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. PMID: 19454434.
      View in: PubMed   Mentions:
    285. Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:140-2. Paulussen M, Bielack S, Jürgens H, Casali PG. PMID: 19454436.
      View in: PubMed   Mentions:
    286. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4:64-7. Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY. PMID: 19454466.
      View in: PubMed   Mentions:
    287. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat Immunol. 2009 May; 10(5):540-50. Park SR, Zan H, Pal Z, Zhang J, Al-Qahtani A, Pone EJ, Xu Z, Mai T, Casali P. PMID: 19363484.
      View in: PubMed   Mentions:
    288. Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). Eur J Cancer. 2009 May; 45(7):1103-1106. Gronchi A, Judson I, Nishida T, Poveda A, Martin J, Reichardt P, Casali PG, Cesne AL, Hohenberger P, Blay JY. PMID: 19286368.
      View in: PubMed   Mentions:
    289. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. Eur J Cancer. 2009 Jul; 45(11):1959-68. George S, Blay JY, Casali PG, Le Cesne A, Stephenson P, Deprimo SE, Harmon CS, Law CN, Morgan JA, Ray-Coquard I, Tassell V, Cohen DP, Demetri GD. PMID: 19282169.
      View in: PubMed   Mentions:
    290. Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009 Apr 20; 27(12):2106-7; author reply 2107-8. Gronchi A, Bonvalot S, Le Cesne A, Casali PG. PMID: 19273692.
      View in: PubMed   Mentions:
    291. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009 May; 251(2):447-56. Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R, Piovesan C, Dileo P, Torri V, Gronchi A, Casali PG. PMID: 19261927.
      View in: PubMed   Mentions:
    292. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. . 2009 Feb; 8(2):449-57. Forni C, Minuzzo M, Virdis E, Tamborini E, Simone M, Tavecchio M, Erba E, Grosso F, Gronchi A, Aman P, Casali P, D'Incalci M, Pilotti S, Mantovani R. PMID: 19190116.
      View in: PubMed   Mentions:
    293. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity. 2009 Feb; 42(2):89-103. Zan H, Zhang J, Ardeshna S, Xu Z, Park SR, Casali P. PMID: 19156553.
      View in: PubMed   Mentions:
    294. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res. 2009 Feb 01; 15(3):1096-104. Stacchiotti S, Tamborini E, Marrari A, Brich S, Rota SA, Orsenigo M, Crippa F, Morosi C, Gronchi A, Pierotti MA, Casali PG, Pilotti S. PMID: 19188185.
      View in: PubMed   Mentions:
    295. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol. 2009 Jul; 35(7):739-45. Fiore M, Palassini E, Fumagalli E, Pilotti S, Tamborini E, Stacchiotti S, Pennacchioli E, Casali PG, Gronchi A. PMID: 19110398.
      View in: PubMed   Mentions:
    296. Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? Transl Oncol. 2008 Dec; 1(4):177-86. Miselli F, Negri T, Gronchi A, Losa M, Conca E, Brich S, Fumagalli E, Fiore M, Casali PG, Pierotti MA, Tamborini E, Pilotti S. PMID: 19043528.
      View in: PubMed   Mentions:
    297. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009 Jan 01; 27(1):24-30. Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, Lozza L, Pennacchioli E, Mariani L, Casali PG. PMID: 19047283.
      View in: PubMed   Mentions:
    298. Stem cell transplantation in autoimmune diseases. Foreword. Autoimmunity. 2008 Dec; 41(8):555. Casali P. PMID: 19117173.
      View in: PubMed   Mentions:
    299. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008 Oct 01; 113(7):1657-65. Mussi C, Collini P, Miceli R, Barisella M, Mariani L, Fiore M, Casali PG, Gronchi A. PMID: 18704991.
      View in: PubMed   Mentions:
    300. The consensus statement on the locoregional treatment of abdominal sarcomatosis. J Surg Oncol. 2008 Sep 15; 98(4):291-4. Rossi CR, Casali P, Kusamura S, Baratti D, Deraco M. PMID: 18726899.
      View in: PubMed   Mentions:
    301. AID- and Ung-dependent generation of staggered double-strand DNA breaks in immunoglobulin class switch DNA recombination: a post-cleavage role for AID. Mol Immunol. 2008 Nov; 46(1):45-61. Zan H, Casali P. PMID: 18760480.
      View in: PubMed   Mentions:
    302. A role for DRAK2 in the germinal center reaction and the antibody response. Autoimmunity. 2008 Aug; 41(5):341-52. Al-Qahtani A, Xu Z, Zan H, Walsh CM, Casali P. PMID: 18568639.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    303. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008 May; 19 Suppl 2:ii35-8. Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY. PMID: 18456761.
      View in: PubMed   Mentions:
    304. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008 May; 19 Suppl 2:ii89-93. Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. PMID: 18456783.
      View in: PubMed   Mentions:
    305. Molecular mechanisms of autoimmunity. Autoimmunity. 2008 Mar; 41(2):123-32. Atassi MZ, Casali P. PMID: 18324481.
      View in: PubMed   Mentions:
    306. The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol. 2007 Dec; 18(12):1923-5. Casali PG. PMID: 18083693.
      View in: PubMed   Mentions:
    307. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2007 Dec; 14(12):3542-51. Baratti D, Pennacchioli E, Casali PG, Bertulli R, Lozza L, Olmi P, Collini P, Radaelli S, Fiore M, Gronchi A. PMID: 17909905.
      View in: PubMed   Mentions:
    308. Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate. Ann Oncol. 2008 Jan; 19(1):173-7. Joensuu H, De Braud F, Coco P, De Pas T, Putzu C, Spreafico C, Bono P, Bosselli S, Jalava T, Laurent D, Casali PG. PMID: 17698976.
      View in: PubMed   Mentions:
    309. Combined modalities approach for localized adult extremity soft-tissue sarcoma. Expert Rev Anticancer Ther. 2007 Aug; 7(8):1135-44. Gronchi A, Olmi P, Casali PG. PMID: 18028022.
      View in: PubMed   Mentions:
    310. Chordoma. Curr Opin Oncol. 2007 Jul; 19(4):367-70. Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. PMID: 17545801.
      View in: PubMed   Mentions:
    311. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007 Jul; 5 Suppl 2:S1-29; quiz S30. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J. PMID: 17624289.
      View in: PubMed   Mentions:
    312. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007 Jul; 8(7):595-602. Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG. PMID: 17586092.
      View in: PubMed   Mentions:
    313. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab. 2007 Sep; 92(9):3531-4. Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casali PG, Beck-Peccoz P, Fugazzola L. PMID: 17595247.
      View in: PubMed   Mentions:
    314. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2007 Jun 15; 109(12):2522-31. Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A. PMID: 17510918.
      View in: PubMed   Mentions:
    315. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors. Clin Cancer Res. 2007 Apr 15; 13(8):2369-77. Miselli FC, Casieri P, Negri T, Orsenigo M, Lagonigro MS, Gronchi A, Fiore M, Casali PG, Bertulli R, Carbone A, Pierotti MA, Tamborini E, Pilotti S. PMID: 17438095.
      View in: PubMed   Mentions:
    316. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J Mol Biol. 2007 May 18; 368(5):1321-31. Duquerroy S, Stura EA, Bressanelli S, Fabiane SM, Vaney MC, Beale D, Hamon M, Casali P, Rey FA, Sutton BJ, Taussig MJ. PMID: 17395205.
      View in: PubMed   Mentions:
    317. Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analysis of EORTC-ISG-AGITG study 62005. Eur J Cancer. 2007 Apr; 43(6):974-8. Verweij J, Casali PG, Kotasek D, Le Cesne A, Reichard P, Judson IR, Issels R, van Oosterom AT, Van Glabbeke M, Blay JY. PMID: 17336514.
      View in: PubMed   Mentions:
    318. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg. 2007 Mar; 245(3):341-6. Gronchi A, Fiore M, Miselli F, Lagonigro MS, Coco P, Messina A, Pilotti S, Casali PG. PMID: 17435538.
      View in: PubMed   Mentions:
    319. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007 May; 14(5):1583-90. Gronchi A, Miceli R, Fiore M, Collini P, Lozza L, Grosso F, Mariani L, Casali PG. PMID: 17260106.
      View in: PubMed   Mentions:
    320. Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient. Br J Cancer. 2007 Jan 15; 96(1):180-1. Negri T, Casieri P, Miselli F, Orsenigo M, Piacenza C, Stacchiotti S, Bidoli P, Casali PG, Pierotti MA, Tamborini E, Pilotti S. PMID: 17213828.
      View in: PubMed   Mentions:
    321. DNA replication to aid somatic hypermutation. Adv Exp Med Biol. 2007; 596:111-27. Xu Z, Zan H, Pal Z, Casali P. PMID: 17338180.
      View in: PubMed   Mentions:
    322. Postoperative radiotherapy for synovial sarcoma of the head and neck during pregnancy: clinical and technical management and fetal dose estimates. Tumori. 2007 Jan-Feb; 93(1):45-52. Orlandi E, Zonca G, Pignoli E, Stucchi C, Borroni M, Collini P, Cantù G, Casali PG, Grosso F, Cerrotta A, Fallai C, Olmi P. PMID: 17455871.
      View in: PubMed   Mentions:
    323. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol. 2007; 27(4):367-97. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P. PMID: 18197815.
      View in: PubMed   Mentions:
    324. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res. 2006 Dec 01; 12(23):6920-8. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S. PMID: 17145809.
      View in: PubMed   Mentions:
    325. Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol. 2007 Feb; 14(2):553-9. Pennacchioli E, Deraco M, Mariani L, Fiore M, Mussi C, Collini P, Olmi P, Casali PG, Santinami M, Gronchi A. PMID: 17122991.
      View in: PubMed   Mentions:
    326. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006 Oct 14; 368(9544):1329-38. Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. PMID: 17046465.
      View in: PubMed   Mentions:
    327. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology. 2006 Oct; 49(4):381-7. Nonaka D, Kusamura S, Baratti D, Casali P, Younan R, Deraco M. PMID: 16978201.
      View in: PubMed   Mentions:
    328. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006 Sep 01; 107(5):1065-74. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, Lozza L, Collini P, Olmi P, Casali PG, Pilotti S, Gronchi A. PMID: 16881077.
      View in: PubMed   Mentions:
    329. Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). Eur J Cancer. 2006 Sep; 42(14):2277-85. Van Glabbeke M, Verweij J, Casali PG, Simes J, Le Cesne A, Reichardt P, Issels R, Judson IR, van Oosterom AT, Blay JY. PMID: 16876399.
      View in: PubMed   Mentions:
    330. Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients. Oncogene. 2006 Oct 05; 25(45):6140-6. Tamborini E, Pricl S, Negri T, Lagonigro MS, Miselli F, Greco A, Gronchi A, Casali PG, Ferrone M, Fermeglia M, Carbone A, Pierotti MA, Pilotti S. PMID: 16751810.
      View in: PubMed   Mentions:
    331. Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma. Eur J Cancer. 2006 Jul; 42(10):1484-90. Grosso F, Dileo P, Sanfilippo R, Stacchiotti S, Bertulli R, Piovesan C, Jimeno J, D'Incalci M, Gescher A, Casali PG. PMID: 16737808.
      View in: PubMed   Mentions:
    332. DNA repair in antibody somatic hypermutation. Trends Immunol. 2006 Jul; 27(7):313-21. Casali P, Pal Z, Xu Z, Zan H. PMID: 16737852.
      View in: PubMed   Mentions:
    333. A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation. J Immunol. 2006 May 01; 176(9):5426-37. Wu X, Tsai CY, Patam MB, Zan H, Chen JP, Lipkin SM, Casali P. PMID: 16622010.
      View in: PubMed   Mentions:
    334. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer. 2006 May; 42(8):1093-103. Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S, Stul M, Casali PG, Zalcberg J, Verweij J, Van Glabbeke M, Hagemeijer A, Judson I. PMID: 16624552.
      View in: PubMed   Mentions:
    335. PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol. 2006 Apr; 208(5):615-23. Lagonigro MS, Tamborini E, Negri T, Staurengo S, Dagrada GP, Miselli F, Gabanti E, Greco A, Casali PG, Carbone A, Pierotti MA, Pilotti S. PMID: 16470538.
      View in: PubMed   Mentions:
    336. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006 Mar; 39(2):137-41. Eliakim A, Schwindt C, Swindt C, Zaldivar F, Casali P, Cooper DM. PMID: 16698670.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    337. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006 Feb; 13(2):229-37. Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S. PMID: 16444562.
      View in: PubMed   Mentions:
    338. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells. Mol Immunol. 2006 Apr; 43(11):1817-26. Komori A, Xu Z, Wu X, Zan H, Casali P. PMID: 16412510.
      View in: PubMed   Mentions:
    339. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006 Jan; 13(1):110-7. Fiore M, Casali PG, Miceli R, Mariani L, Bertulli R, Lozza L, Collini P, Olmi P, Mussi C, Gronchi A. PMID: 16372156.
      View in: PubMed   Mentions:
    340. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution. Cancer. 2005 Nov 15; 104(10):2181-8. Nonaka D, Kusamura S, Baratti D, Casali P, Cabras AD, Younan R, Rosai J, Deraco M. PMID: 16206294.
      View in: PubMed   Mentions:
    341. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005 Oct 20; 23(30):7669-75. Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, Collini P, Olmi P, Casali PG, Gronchi A. PMID: 16234529.
      View in: PubMed   Mentions:
    342. The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J. 2005 Nov 02; 24(21):3757-69. Zan H, Shima N, Xu Z, Al-Qahtani A, Evinger Iii AJ, Zhong Y, Schimenti JC, Casali P. PMID: 16222339.
      View in: PubMed   Mentions:
    343. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer. 2005 Sep; 12(3):657-66. Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L. PMID: 16172198.
      View in: PubMed   Mentions:
    344. Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. J Clin Oncol. 2005 Aug 20; 23(24):5795-804. Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PC, Brown M, Bertulli R, Judson IR. PMID: 16110036.
      View in: PubMed   Mentions:
    345. Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. Eur J Cancer. 2005 Aug; 41(12):1751-7. Zalcberg JR, Verweij J, Casali PG, Le Cesne A, Reichardt P, Blay JY, Schlemmer M, Van Glabbeke M, Brown M, Judson IR. PMID: 16098458.
      View in: PubMed   Mentions:
    346. Adjuvant chemotherapy for soft tissue sarcoma. Curr Opin Oncol. 2005 Jul; 17(4):361-5. Casali PG, Picci P. PMID: 15933469.
      View in: PubMed   Mentions:
    347. DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation. Ann N Y Acad Sci. 2005 Jun; 1050:146-62. Xu Z, Fulop Z, Zhong Y, Evinger AJ, Zan H, Casali P. PMID: 16014529.
      View in: PubMed   Mentions:
    348. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol. 2005 Apr; 16(4):566-78. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Mac Clure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD. PMID: 15781488.
      View in: PubMed   Mentions:
    349. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005 Jan 15; 103(2):402-8. Mariani L, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, Casali PG, Gronchi A. PMID: 15578681.
      View in: PubMed   Mentions:
    350. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005 Jan 01; 23(1):96-104. Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, Rosai J. PMID: 15625364.
      View in: PubMed   Mentions:
    351. Carney triad: case report and molecular analysis of gastric tumor. Hum Pathol. 2005 Jan; 36(1):112-6. Diment J, Tamborini E, Casali P, Gronchi A, Carney JA, Colecchia M. PMID: 15712189.
      View in: PubMed   Mentions:
    352. Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: a feasiblity study. J Chemother. 2004 Nov; 16 Suppl 5:19-22. Kusamura S, Raspagliesi F, Baratti D, Gronchi A, Casali P, Deraco M. PMID: 15675470.
      View in: PubMed   Mentions:
    353. Imatinib mesylate in chordoma. Cancer. 2004 Nov 01; 101(9):2086-97. Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. PMID: 15372471.
      View in: PubMed   Mentions:
    354. Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors. J Chemother. 2004 Nov; 16 Suppl 4:55-8. Casali PG, Bertulli R, Fumagalli E, Coco P, Grosso F, Stacchiotti S. PMID: 15688611.
      View in: PubMed   Mentions:
    355. Class switching and Myc translocation: how does DNA break? Nat Immunol. 2004 Nov; 5(11):1101-3. Casali P, Zan H. PMID: 15496946.
      View in: PubMed   Mentions:
    356. Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions. Autoimmunity. 2004 Sep-Nov; 37(6-7):431-443. Liu S, Cerutti A, Casali P, Crow MK. PMID: 15621569.
      View in: PubMed   Mentions:
    357. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004 Sep 25-Oct 1; 364(9440):1127-34. Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I. PMID: 15451219.
      View in: PubMed   Mentions:
    358. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004 Aug 01; 101(3):627-34. Ferrari A, Gronchi A, Casanova M, Meazza C, Gandola L, Collini P, Lozza L, Bertulli R, Olmi P, Casali PG. PMID: 15274077.
      View in: PubMed   Mentions:
    359. The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem. 2004 Oct 01; 279(40):42258-69. Kim EC, Edmonston CR, Wu X, Schaffer A, Casali P. PMID: 15252056.
      View in: PubMed   Mentions:
    360. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. Gastroenterology. 2004 Jul; 127(1):294-9. Tamborini E, Bonadiman L, Greco A, Albertini V, Negri T, Gronchi A, Bertulli R, Colecchia M, Casali PG, Pierotti MA, Pilotti S. PMID: 15236194.
      View in: PubMed   Mentions:
    361. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004 Jun 01; 100(11):2448-55. Gronchi A, Casali PG, Fiore M, Mariani L, Lo Vullo S, Bertulli R, Colecchia M, Lozza L, Olmi P, Santinami M, Rosai J. PMID: 15160351.
      View in: PubMed   Mentions:
    362. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin Cancer Res. 2004 Feb 01; 10(3):938-43. Tamborini E, Bonadiman L, Greco A, Gronchi A, Riva C, Bertulli R, Casali PG, Pierotti MA, Pilotti S. PMID: 14871970.
      View in: PubMed   Mentions:
    363. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003 Dec; 112(11):1644-54. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE. PMID: 14660741.
      View in: PubMed   Mentions:
    364. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol. 2003 Nov 15; 171(10):5215-24. He B, Raab-Traub N, Casali P, Cerutti A. PMID: 14607922.
      View in: PubMed   Mentions:
    365. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003 Aug 01; 98(3):571-80. Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F, Casali PG. PMID: 12879475.
      View in: PubMed   Mentions:
    366. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol. 2003 Jul; 83(3):147-53. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. PMID: 12827682.
      View in: PubMed   Mentions:
    367. Immunoglobulin somatic hypermutation: double-strand DNA breaks, AID and error-prone DNA repair. J Clin Immunol. 2003 Jul; 23(4):235-46. Wu X, Feng J, Komori A, Kim EC, Zan H, Casali P. PMID: 12959216.
      View in: PubMed   Mentions:
    368. [Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research]. Tumori. 2003 Jul-Aug; 89(4 Suppl):56-7. Deraco M, Kusamura S, Baratti D, Casali P, Zaffaroni N. PMID: 12903546.
      View in: PubMed   Mentions:
    369. AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity. 2003 Jun; 18(6):727-38. Zan H, Wu X, Komori A, Holloman WK, Casali P. PMID: 12818155.
      View in: PubMed   Mentions:
    370. Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements. J Biol Chem. 2003 Jun 20; 278(25):23141-50. Schaffer A, Kim EC, Wu X, Zan H, Testoni L, Salamon S, Cerutti A, Casali P. PMID: 12672812.
      View in: PubMed   Mentions:
    371. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003 Apr 01; 21(7):1390-7. Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M, Rosai J. PMID: 12663732.
      View in: PubMed   Mentions:
    372. Gastrointestinal stromal tumors: should they be treated with the same systemic chemotherapy as other soft tissue sarcomas? Oncology. 2003; 64(2):186-8. de Pas T, Casali PG, Toma S, Romanini A, Massidda B, Comandone A, Labianca R, Massacesi C, Tucci A, Antimi M, Biasco G, Aglietta M, Apice G, de Braud F. PMID: 12566918.
      View in: PubMed   Mentions:
    373. Diversity and somatic hypermutation of the Ig VHDJH, V kappa J kappa, and V lambda J lambda gene segments in lymphoma B cells: relevance to the origin of the neoplastic B cell clone. Hum Immunol. 2003 Jan; 64(1):69-81. Riboldi P, Ikematsu W, Brambilla B, Caprani C, Gerosa M, Casali P. PMID: 12507816.
      View in: PubMed   Mentions:
    374. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol. 2002 Dec 01; 169(11):6594-603. Cerutti A, Zan H, Kim EC, Shah S, Schattner EJ, Schaffer A, Casali P. PMID: 12444172.
      View in: PubMed   Mentions:
    375. Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J Exp Med. 2002 Sep 02; 196(5):629-39. Gurrieri C, McGuire P, Zan H, Yan XJ, Cerutti A, Albesiano E, Allen SL, Vinciguerra V, Rai KR, Ferrarini M, Casali P, Chiorazzi N. PMID: 12208878.
      View in: PubMed   Mentions:
    376. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002 Sep; 3(9):822-9. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. PMID: 12154359.
      View in: PubMed   Mentions:
    377. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis. Autoimmunity. 2002 Jul; 35(4):283-9. Schattner EJ, Friedman SM, Casali P. PMID: 12482198.
      View in: PubMed   Mentions:
    378. Somatic immunoglobulin hypermutation. Curr Opin Immunol. 2002 Apr; 14(2):235-40. Diaz M, Casali P. PMID: 11869898.
      View in: PubMed   Mentions:
    379. SYT-SSX fusion genes and prognosis in synovial sarcoma. Br J Cancer. 2001 Nov 16; 85(10):1535-9. Mezzelani A, Mariani L, Tamborini E, Agus V, Riva C, Lo Vullo S, Fabbri A, Stumbo M, Azzarelli A, Casali PG, Gronchi A, Sozzi G, Pierotti MA, Pilotti S. PMID: 11720441.
      View in: PubMed   Mentions:
    380. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 2001 Sep 01; 92(5):1259-64. Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A, Pilotti S, Casali PG. PMID: 11571741.
      View in: PubMed   Mentions:
    381. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity. 2001 May; 14(5):643-53. Zan H, Komori A, Li Z, Cerutti A, Schaffer A, Flajnik MF, Diaz M, Casali P. PMID: 11371365.
      View in: PubMed   Mentions:
    382. IgG2a and igA co-expression by the natural autoantibody-producing murine B lymphoma T560. Autoimmunity. 2001 May; 33(3):181-97. Phillips-Quagliata JM, Faria AM, Han J, Spencer DH, Haughton G, Casali P. PMID: 11683378.
      View in: PubMed   Mentions:
    383. Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells. Nat Immunol. 2001 Feb; 2(2):150-6. Cerutti A, Kim EC, Shah S, Schattner EJ, Zan H, Schaffer A, Casali P. PMID: 11175813.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    384. Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by molecular diagnostic studies. Am J Surg Pathol. 2001 Feb; 25(2):273-4. Collini P, Sampietro G, Bertulli R, Casali PG, Luksch R, Mezzelani A, Sozzi G, Pilotti S. PMID: 11176079.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    385. Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution. Hum Immunol. 2000 Dec; 61(12):1242-53. Ikematsu H, Cerutti A, Zan H, Knowles DM, Ikematsu W, Casali P. PMID: 11163079.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    386. QUOROM and the search for an updated 'clinical method' in the era of evidence-based medicine. Ann Oncol. 2000 Aug; 11(8):923-5. Casali PG, Licitra L, Bruzzi P. PMID: 11038027.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    387. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J Immunol. 2000 Jul 15; 165(2):786-94. Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, Ely S, Casali P. PMID: 10878352.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    388. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation. J Immunol. 2000 Jul 15; 165(2):830-9. Zan H, Li Z, Yamaji K, Dramitinos P, Cerutti A, Casali P. PMID: 10878357.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    389. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death. Cell Immunol. 2000 Jul 10; 203(1):1-11. Stohl W, Xu D, Starling GC, Casali P, Kiener PA. PMID: 10915556.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    390. Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol. 2000 Jul; 30(7):2015-26. Li Z, Schettino EW, Padlan EA, Ikematsu H, Casali P. PMID: 10940891.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    391. Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma. Lab Invest. 2000 Jun; 80(6):805-13. Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S. PMID: 10879732.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    392. Outcome assessment in cancer management. Surg Clin North Am. 2000 Apr; 80(2):471-86, viii. Tamburini M, Casali PG, Miccinesi G. PMID: 10836002.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    393. Cancer patients as 'experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO). Qual Life Res. 2000 Mar; 9(2):151-9. Costantini M, Mencaglia E, Giulio PD, Cortesi E, Roila F, Ballatori E, Tamburini M, Casali P, Licitra L, Candis DD, Massidda B, Luzzani M, Campora E, Placido SD, Palmeri S, Angela PM, Baracco G, Gareri R, Martignetti A, Ragosa S, Zoda L, Ionta MT, Bulletti S, Pastore L. PMID: 10983479.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    394. Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors. Tumori. 1999 Jul-Aug; 85(4):229-33. Frustaci S, Buonadonna A, Romanini A, Comandone A, Dalla Palma M, Gamucci T, Verusio C, Lionetto R, Dani C, Casali P, Santoro A. PMID: 10587022.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    395. START: a European state-of-the-art on-line instrument for clinical oncologists. Ann Oncol. 1999 Jul; 10(7):769-73. Casali P, Licitra L, Tondini C, de Braud F, Bruzzi P, Costa A, Cavalli F. PMID: 10470422.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    396. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites. J Immunol. 1999 May 01; 162(9):5327-36. Schaffer A, Cerutti A, Shah S, Zan H, Casali P. PMID: 10228008.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    397. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol. 1999 04; 29(4):1253-64. Matolcsy A, Schattner EJ, Knowles DM, Casali P. PMID: 10229093.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    398. Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation. J Immunol. 1999 Mar 15; 162(6):3437-47. Zan H, Cerutti A, Dramitinos P, Schaffer A, Li Z, Casali P. PMID: 10092799.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    399. The IgG2a/IgA produced by the murine T560 B lymphoma that arose during a graft-versus-host reaction is polyreactive and somatically mutated. Autoimmunity. 1999; 29(3):215-33. Phillips-Quagliata JM, Faria AM, Han J, Spencer DH, Haughton G, Casali P. PMID: 10433101.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    400. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination. J Immunol. 1998 Nov 15; 161(10):5217-25. Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P. PMID: 9820493.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    401. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation. J Immunol. 1998 Sep 15; 161(6):2895-905. Ikematsu W, Kobarg J, Ikematsu H, Ichiyoshi Y, Casali P. PMID: 9743351.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    402. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. Immunity. 1998 Aug; 9(2):247-56. Cerutti A, Schaffer A, Shah S, Zan H, Liou HC, Goodwin RG, Casali P. PMID: 9729045.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    403. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum. 1998 Jun; 41(6):1026-39. Ikematsu W, Luan FL, La Rosa L, Beltrami B, Nicoletti F, Buyon JP, Meroni PL, Balestrieri G, Casali P. PMID: 9627012.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    404. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol. 1998 Mar 01; 160(5):2145-57. Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max EE, Casali P. PMID: 9498752.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    405. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol. 1998 Jan 15; 160(2):820-30. Schettino EW, Cerutti A, Chiorazzi N, Casali P. PMID: 9551917.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    406. Quality of life assessment and clinical decision-making. Ann Oncol. 1997 Dec; 8(12):1207-11. Casali P, Licitra L, Costantini M, Santoro A, Viterbori P, Bajetta E, Bruzzi P. PMID: 9496385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    407. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells. Blood. 1997 Mar 01; 89(5):1732-9. Matolcsy A, Casali P, Nádor RG, Liu YF, Knowles DM. PMID: 9057657.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    408. VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol. 1997 Mar 01; 158(5):2477-89. Schettino EW, Chai SK, Kasaian MT, Schroeder HW, Casali P. PMID: 9037000.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    409. [Evaluation of quality of life in oncology. Rationale and objectives of the first phase of the Quality of Life in Oncology project]. Tumori. 1997; 83(2 Suppl):S25-7. Costantini M, Mencaglia E, Di Giulio P, Cortesi E, Roila F, Ballatori E, Tamburini M, Casali P, Licitra L, Massidda B, Luzzani M, Campora E, De Placido S, Palmeri S, Palladino MA, Baracco G, Gareri R, Martignetti A, Ragosa S, Zoda L, Ionta MT, Bulletti S, Pastore L. PMID: 9235726.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    410. Soft tissue and bone sarcomas. Cancer Chemother Biol Response Modif. 1997; 17:612-8. Santoro A, Casali P. PMID: 9551232.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    411. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood. 1996 Nov 15; 88(10):3937-44. Matolcsy A, Casali P, Warnke RA, Knowles DM. PMID: 8916960.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    412. Analysis of the structural correlates for self-antigen binding by natural and disease-related autoantibodies. In vitro expression of recombinant and/or mutagenized human IgG. Ann N Y Acad Sci. 1995 Sep 29; 764:328-41. Ichiyoshi Y, Casali P. PMID: 7486543.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    413. Clonal analysis of IgM+ CD5+ CLL B cells. Ann N Y Acad Sci. 1995 Sep 29; 764:485-91. Schettino EW, Newcomb EW, Potmesil M, Inghirami G, Casali P. PMID: 7486572.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    414. Structure of the VH-D-JH segments of human natural polyreactive IgM and IgG antibodies. Use of germline or somatically mutated forms of commonly expressed VH genes. Ann N Y Acad Sci. 1995 Sep 29; 764:362-9. Ikematsu H, Schettino EW, Casali P. PMID: 7486547.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    415. Cellular origin, antigen reactivity, and VH segment structure of IgM mAbs from AIDS lymphomas. Ann N Y Acad Sci. 1995 Sep 29; 764:509-18. Riboldi P, Gaidano G, Schettino EW, Knowles DM, Dalla-Favera R, Casali P. PMID: 7486578.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    416. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann N Y Acad Sci. 1995 Sep 29; 764:410-23. Kasaian MT, Casali P. PMID: 7486556.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    417. A sequence analysis of human germline Ig VH and VL genes. The CDR1s of a major proportion of VH, but not VL, genes display a high inherent susceptibility to amino acid replacement. Ann N Y Acad Sci. 1995 Sep 29; 764:170-9. Chang B, Casali P. PMID: 7486517.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    418. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome. Ann N Y Acad Sci. 1995 Sep 29; 764:496-503. Matolcsy A, Casali P, Knowles DM. PMID: 7486574.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    419. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1995 Jul; 13(7):1537-45. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E. PMID: 7602342.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCTClinical Trials
    420. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis. J Immunol. 1995 Jan 01; 154(1):226-38. Ichiyoshi Y, Zhou M, Casali P. PMID: 7995943.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    421. Kinetics and calcium-specificity of polyamine uptake in carrot protoplasts. Amino Acids. 1994 Oct; 6(3):301-9. Antognoni F, Casali P, Pistocchi R, Bagni N. PMID: 24189738.
      View in: PubMed   Mentions:
    422. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med. 1994 Sep 01; 180(3):885-95. Ichiyoshi Y, Casali P. PMID: 8064239.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    423. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today. 1994 Aug; 15(8):367-73. Chang B, Casali P. PMID: 7916950.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    424. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood. 1994 May 15; 83(10):2952-61. Riboldi P, Gaidano G, Schettino EW, Steger TG, Knowles DM, Dalla-Favera R, Casali P. PMID: 8180391.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    425. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol. 1994 Mar 15; 152(6):3137-51. Kasaian MT, Ikematsu H, Balow JE, Casali P. PMID: 8144908.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    426. VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection. J Immunol. 1994 Feb 01; 152(3):1430-41. Ikematsu H, Ichiyoshi Y, Schettino EW, Nakamura M, Casali P. PMID: 8301143.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    427. Natural autoantibodies. Adv Exp Med Biol. 1994; 347:147-59. Chai SK, Mantovani L, Kasaian MT, Casali P. PMID: 7526635.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    428. Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Int Immunol. 1993 Dec; 5(12):1523-33. Harindranath N, Ikematsu H, Notkins AL, Casali P. PMID: 8312222.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    429. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol. 1993 Oct 01; 151(7):3604-16. Ikematsu H, Kasaian MT, Schettino EW, Casali P. PMID: 8376796.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    430. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol. 1993 Jul 01; 151(1):473-88. Mantovani L, Wilder RL, Casali P. PMID: 7686945.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    431. Drugs ten years later: epirubicin. Ann Oncol. 1993 May; 4(5):359-69. Bonadonna G, Gianni L, Santoro A, Bonfante V, Bidoli P, Casali P, Demicheli R, Valagussa P. PMID: 8353070.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    432. Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene. J Immunol Methods. 1993 Mar 15; 160(1):19-25. Shammah S, Mantovani TL, Dalla-Favera R, Casali P. PMID: 8450236.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    433. Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J Immunol. 1993 Feb 15; 150(4):1325-37. Ikematsu H, Harindranath N, Ueki Y, Notkins AL, Casali P. PMID: 8432980.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    434. Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas. Cancer Chemother Pharmacol. 1993; 31 Suppl 2:S228-32. Casali P, Pastorino U, Azzarelli A, Bertulli R, Zucchinelli P, Devizzi L, Santoro A. PMID: 8453704.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    435. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity. 1993; 15(4):315-29. Kasaian MT, Casali P. PMID: 7511005.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    436. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities. Cancer Chemother Pharmacol. 1993; 31 Suppl 2:S210-2. Azzarelli A, Quagliuolo V, Casali P, Fissi S, Montalto F, Santoro A. PMID: 8453700.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    437. Generation of Human Monoclonal Autoantibody-Producing Cell Lines by Epstein-Barr Virus Transformation of Autoreactive B Lymphocytes and by Somatic Cell Hybridization Techniques: Application to the Analysis of the Autoimmune B Cell Repertoire. Immunomethods. 1992 Dec; 1(3):159-168. Nakamura M, Casali P. PMID: 26937163.
      View in: PubMed   Mentions:
    438. Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors. J Immunol. 1992 Sep 01; 149(5):1817-24. Williams RC, Malone CC, Casali P. PMID: 1380541.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    439. Somatic mutations in the VH genes of high-affinity antibodies to self and foreign antigens produced by human CD5+ and CD5- B lymphocytes. Ann N Y Acad Sci. 1992 May 04; 651:319-27. Ikematsu H, Harindranath N, Casali P. PMID: 1376051.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    440. Analysis of the human CD5- CD45RAlow B-cell subset. Ann N Y Acad Sci. 1992 May 04; 651:59-69. Kasaian MT, Casali P. PMID: 1376086.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    441. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol. 1992 May 01; 148(9):2690-702. Kasaian MT, Ikematsu H, Casali P. PMID: 1374094.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    442. Intra-arterial induction chemotherapy for soft tissue sarcomas. Ann Oncol. 1992 Apr; 3 Suppl 2:S67-70. Azzarelli A, Quagliuolo V, Fissi S, Casali P, Garbuglia A, Bignami P, Santoro A, Andreola S, Gennari L. PMID: 1622871.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    443. Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas. Ann Oncol. 1992 Apr; 3 Suppl 2:S125-6. Casali P, Pastorino U, Zucchinelli P, Devizzi L, Azzarelli A, Quagliuolo V, Bignami P, Santoro A, Bonadonna G. PMID: 1622854.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    444. Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol. 1991 Sep; 3(9):865-75. Harindranath N, Goldfarb IS, Ikematsu H, Burastero SE, Wilder RL, Notkins AL, Casali P. PMID: 1718404.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    445. Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection. J Immunol. 1991 Jul 01; 147(1):102-8. Dhawan S, Streicher HZ, Wahl LM, Miller N, Louie AT, Goldfarb IS, Jackson WL, Casali P, Notkins AL. PMID: 1646840.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    446. CD5+ B lymphocytes. . 1991 Jul; 197(3):226-41. Kasaian MT, Ikematsu H, Casali P. PMID: 1712492.
      View in: PubMed   Mentions:
    447. Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma. Am J Clin Oncol. 1990 Oct; 13(5):424-6. Bidoli P, Spinazzè S, Santoro A, Casali P, Bedini AV, Guzzon A. PMID: 2171319.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    448. [Adjuvant chemotherapy of colorectal carcinoma]. Ann Ital Chir. 1990 Sep-Oct; 61(5):509-13. Casali P, Licitra L, Alafaci E, Gennari L. PMID: 2100969.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    449. Results of salvage surgery for metastatic sarcomas. Ann Oncol. 1990 Jul; 1(4):269-73. Pastorino U, Valente M, Santoro A, Gasparini M, Azzarelli A, Casali P, Tavecchio L, Rayasi G. PMID: 2265136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    450. Biological characterization of human monoclonal antibodies to rabies virus. J Virol. 1990 Jun; 64(6):3087-90. Dietzschold B, Gore M, Casali P, Ueki Y, Rupprecht CE, Notkins AL, Koprowski H. PMID: 2335829.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    451. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J Immunol. 1990 May 15; 144(10):3741-7. Casali P, Nakamura M, Ginsberg-Fellner F, Notkins AL. PMID: 2159034.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    452. Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst. 1990 Mar 21; 82(6):469-77. Gianni L, Viganò L, Surbone A, Ballinari D, Casali P, Tarella C, Collins JM, Bonadonna G. PMID: 2313718.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    453. Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. J Exp Med. 1990 Jan 01; 171(1):19-34. Ueki Y, Goldfarb IS, Harindranath N, Gore M, Koprowski H, Notkins AL, Casali P. PMID: 2153188.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    454. Median sternotomy and multiple lung resections for metastatic sarcomas. Eur J Cardiothorac Surg. 1990; 4(9):477-81. Pastorino U, Valente M, Gasparini M, Azzarelli A, Santoro A, Tavecchio L, Casali P, Ravasi G. PMID: 2223127.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    455. Polyclonal B cell activation and antigen-driven antibody response as mechanisms of autoantibody production in SLE. Autoimmunity. 1990; 5(3):147-50. Casali P. PMID: 2129748.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    456. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. J Immunol. 1989 Dec 01; 143(11):3476-83. Casali P, Burastero SE, Balow JE, Notkins AL. PMID: 2479680.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    457. Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol. 1989 Jun 01; 142(11):4054-61. Sanz I, Casali P, Thomas JW, Notkins AL, Capra JD. PMID: 2497188.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    458. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce. Contrib Microbiol Immunol. 1989; 11:231-62. Burastero SE, Casali P. PMID: 2479500.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    459. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J Immunol. 1988 Dec 15; 141(12):4165-72. Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. PMID: 2848890.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    460. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med. 1988 Dec 01; 168(6):1979-92. Burastero SE, Casali P, Wilder RL, Notkins AL. PMID: 3264319.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    461. Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. J Virol. 1988 Jul; 62(7):2453-63. Inghirami G, Nakamura M, Balow JE, Notkins AL, Casali P. PMID: 2836625.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    462. Characterization of multireactive autoantibodies and identification of Leu-1+ B lymphocytes as cells making antibodies binding multiple self and exogenous molecules. Int Rev Immunol. 1988 Mar; 3(1-2):17-45. Casali P, Prabhakar BS, Notkins AL. PMID: 3073178.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    463. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science. 1987 Apr 03; 236(4797):77-81. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. PMID: 3105056.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    464. Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. Science. 1986 Oct 24; 234(4775):476-9. Casali P, Inghirami G, Nakamura M, Davies TF, Notkins AL. PMID: 3020687.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    465. Immune balance in the cytomegalovirus-infected host: in vitro studies of virus-lymphocyte interactions and the effects on specific lymphocyte function. Birth Defects Orig Artic Ser. 1984; 20(1):149-59. Casali P, Rice GP, Oldstone MB. PMID: 6329358.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    466. Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J Immunol. 1981 Nov; 127(5):2146-50. Härfast B, Huddlestone JR, Casali P, Merigan TC, Oldstone MB. PMID: 6170691.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    467. Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests. Clin Exp Immunol. 1977 Aug; 29(2):342-54. Casali P, Bossus A, Carpentier NA, Lambert PH. PMID: 332422.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimals
    468. Expression of Fc and complement receptors on T lymphocytes activated in vitro by phytohaemagglutinin (PHA). Immunology. 1977 Jun; 32(6):827-30. Smeraldi RS, Villa MG, Perussia B, Fabio G, Casali P, Rugarli C. PMID: 301853.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    469. Immunological status of aged subjects with reference to serological evidence of autoimmunity. Ric Clin Lab. 1977 Apr-Jun; 7(2):115-23. Zanussi C, Rugarli C, Casali P, Fabio G, Perussia B, Sabbadini Villa MG, Scorza Smeraldi R, Duca G. PMID: 303369.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    470. C3-reacted sepharose: a preparative method for separating T and B lymphocytes. Clin Exp Immunol. 1977 Jan; 27(1):38-42. Casali P, Perussia BM. PMID: 300306.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    471. Complement receptors (C3b, C4b/C3d) unbalance on CLL lymphocytes. Boll Ist Sieroter Milan. 1976 Jul 31; 55(3):235-40. Perussia B, Casali P, Joppolo G, Borzini P. PMID: 1087884.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    Paolo's Networks
    Concepts (1149)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _